{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:48:14Z","timestamp":1791388094561,"version":"4.3.3"},"reference-count":300,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007351","name":"Universidad de Buenos Aires Secretaria de Ciencia y Tecnica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007351","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010253","name":"Secretar\u00eda de Ciencia y T\u00e9cnica, Universidad de Buenos Aires","doi-asserted-by":"publisher","award":["UBACYT 20020170100054BA"],"award-info":[{"award-number":["UBACYT 20020170100054BA"]}],"id":[{"id":"10.13039\/501100010253","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010253","name":"Secretar\u00eda de Ciencia y T\u00e9cnica, Universidad de Buenos Aires","doi-asserted-by":"publisher","award":["20020220300188BA"],"award-info":[{"award-number":["20020220300188BA"]}],"id":[{"id":"10.13039\/501100010253","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.bcp.2024.116164","type":"journal-article","created":{"date-parts":[[2024,3,24]],"date-time":"2024-03-24T19:52:55Z","timestamp":1711309975000},"page":"116164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["H2 antihistamines: May be useful for combination therapies in cancer?"],"prefix":"10.1016","volume":"223","author":[{"given":"Nora A.","family":"Mohamad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara E.","family":"Galarza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4760-5130","authenticated-orcid":false,"given":"Gabriela A.","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bcp.2024.116164_b0005","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bcp.2024.116164_b0010","series-title":"Histamine: Biology and Medical Aspects","first-page":"31","article-title":"Histidine decarboxylase (HDC) enzyme and gene","author":"Darvas","year":"2004"},{"key":"10.1016\/j.bcp.2024.116164_b0015","doi-asserted-by":"crossref","unstructured":"Y. Konttinen, H. Husu, X. Han, M.Passani, C. Ballerini, V. Stegaev, T. Sillat, Z. Mackiewicz. Chapter 7 Non-professional histamine producing cells, immune responses and autoimmunity.In: Histamine H4 receptor. Holger Stark (Ed). Versita Ltd, 78 York Street, London W1H 1DP, Great Britain. De Gruyter Open Poland, 2014, pp. 201-258.https:\/\/doi.org\/10.2478\/9788376560564.c7.","DOI":"10.2478\/9788376560564.c7"},{"issue":"5","key":"10.1016\/j.bcp.2024.116164_b0020","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1111\/bjd.14995","article-title":"Histamine metabolism and transport are deranged in human keratinocytes in oral lichen planus","volume":"176","author":"Salem","year":"2017","journal-title":"Br. J. Dermatol."},{"issue":"12","key":"10.1016\/j.bcp.2024.116164_b0025","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1111\/j.1365-2222.2009.03374.x","article-title":"Histamine, histamine receptors and their role in immune pathology","volume":"39","author":"Jutel","year":"2009","journal-title":"Clin. Exp. Allergy"},{"issue":"3","key":"10.1016\/j.bcp.2024.116164_b0030","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1124\/pr.114.010249","article-title":"International union of basic and clinical pharmacology XCVIII. Histamine receptors","volume":"67","author":"Panula","year":"2015","journal-title":"Pharmacol Rev."},{"key":"10.1016\/j.bcp.2024.116164_b0035","unstructured":"S.J. Hill, C.R. Ganellin, H. Timmerman, J.C. Schwartz, N.P. Shankley, J.M. Young, W. Schunack, R. Levi, H.L. Haas. International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol Rev. 1997 Sep;49(3):253-78. PMID: 9311023."},{"key":"10.1016\/j.bcp.2024.116164_b0040","doi-asserted-by":"crossref","unstructured":"S. Tanaka, A. Ichikawa. Regulation of mammalian histamine synthesis: histidine decarboxylase. In: Biomedical Aspects of Histamine Current Perspectives. Shahid N, Khardori RA, Khan T, Tripathi (Eds.). 2011, pp. 15-30. New York, NY: Springer.","DOI":"10.1007\/978-90-481-9349-3_2"},{"issue":"10","key":"10.1016\/j.bcp.2024.116164_b0045","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/S0006-2952(02)00975-9","article-title":"Regulation of phospholipase C activation by the number of H(2) receptors during Ca(2+)-induced differentiation of mouse keratinocytes","volume":"63","author":"Fitzsimons","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116164_b0050","doi-asserted-by":"crossref","unstructured":"R. Leurs, H.F. Vischer, M. Wijtmans, I.J. de Esch. En route to new blockbuster anti-histamines: surveying the offspring of the expanding histamine receptor family. Trends Pharmacol Sci. 2011 Apr;32(4):250-7. https:\/\/doi.org\/10.1016\/j.tips.2011.02.004. Epub 2011 Mar 15. Erratum in: Trends Pharmacol Sci. 2012 Jan;33(1):49. PMID: 21414671.","DOI":"10.1016\/j.tips.2011.10.003"},{"key":"10.1016\/j.bcp.2024.116164_b0055","doi-asserted-by":"crossref","unstructured":"N. Alonso, N. Fernandez, C. Notcovich, F. Monczor, M. Simaan, A. Baldi, J.S. Gutkind, C. Davio, C. Shayo, Cross-desensitization and cointernalization of H1 and H2 histamine receptors reveal new insights into histamine signal integration, Mol. Pharmacol. 83 (5) (2013 May) 1087\u20131098. https:\/\/doi.org\/10.1124\/mol.112.083394. Epub 2013 Mar 5. PMID: 23462507; PMCID: PMC3629830.","DOI":"10.1124\/mol.112.083394"},{"issue":"5347","key":"10.1016\/j.bcp.2024.116164_b0060","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/236385a0","article-title":"Definition and antagonism of histamine H 2 -receptors","volume":"236","author":"Black","year":"1972","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.bcp.2024.116164_b0065","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1073\/pnas.88.2.429","article-title":"Molecular cloning of a gene encoding the histamine H2 receptor","volume":"88","author":"Gantz","year":"1991","journal-title":"PNAS"},{"issue":"3","key":"10.1016\/j.bcp.2024.116164_b0070","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/0006-291X(91)91047-G","article-title":"Molecular cloning of the human histamine H2 receptor","volume":"178","author":"Gantz","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.bcp.2024.116164_b0075","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1016\/0006-291X(91)91738-X","article-title":"Cloning and tissue expression of a rat histamine H2-receptor gene","volume":"179","author":"Ruat","year":"1991","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"3","key":"10.1016\/j.bcp.2024.116164_b0080","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1006\/geno.1996.0575","article-title":"Cloning, RNexpression, and chromosomal location of a mouse histamine H2 receptor gene","volume":"37","author":"Kobayashi","year":"1996","journal-title":"Genomics"},{"key":"10.1016\/j.bcp.2024.116164_b0085","unstructured":"L. Fagerberg, B.M. Hallstr\u00f6m, P. Oksvold, C. Kampf, D. Djureinovic, J. Odeberg. Et al., Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics. 2014 Feb;13(2):397-406. https:\/\/doi.org\/10.1074\/mcp.M113.035600. Epub 2013 Dec 5. PMID: 24309898; PMCID: PMC3916642. https:\/\/www.ebi.ac.uk\/gxa\/experiments\/E-MTAB-1733\/Results?specific=true&geneQuery=%255B%257B%2522value%2522%253A%2522HRH2%2522%252C%2522category%2522%253A%2522symbol%2522%257D%255D&filterFactors=%257B%257D&cutoff=%257B%2522value%2522%253A0.5%257D&unit=%2522FPKM%2522. Accessed September 9, 2023."},{"key":"10.1016\/j.bcp.2024.116164_b0090","doi-asserted-by":"crossref","unstructured":"P. Chazot, M. Cowart, H. Fukui, C.R. Ganellin, R. Gutzmer, H.L. Haas, S.J. Hill, R. Hills, R. Leurs, R. Levi, S. Liu, P. Panula, W. Schunack, J.-C. Schwartz, R. Seifert, N.P. Shankley, H. Stark, R. Thurmond, H. Timmerman, Y.J.M. Histamine. Receptors in GtoPdb V.2023.1. GtoPdb CITE 2023, 2023. Available from:https:\/\/doi.org\/10.2218\/gtopdb\/F33\/2023.1. Accessed September 9, 2023.","DOI":"10.2218\/gtopdb\/F33\/2023.1"},{"key":"10.1016\/j.bcp.2024.116164_b0095","unstructured":"Human Protein Atlas. HRH2. data available from v23.proteinatlas.org. https:\/\/www.proteinatlas.org\/ENSG00000113749-HRH2\/. Accessed August 9, 2023."},{"issue":"13","key":"10.1016\/j.bcp.2024.116164_b0100","doi-asserted-by":"crossref","first-page":"6802","DOI":"10.1073\/pnas.93.13.6802","article-title":"Inverse agonism of histamine H2 antagonist accounts for upregulation of spontaneously active histamine H2 receptors","volume":"93","author":"Smit","year":"1996","journal-title":"PNAS"},{"issue":"3","key":"10.1016\/j.bcp.2024.116164_b0105","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0002-9440(10)63176-8","article-title":"Attenuation of Th1 effector cell responses and susceptibility to experimental allergic encephalomyelitis in histamine H2 receptor knockout mice is due to dysregulation of cytokine production by antigen-presenting cells","volume":"164","author":"Teuscher","year":"2004","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.bcp.2024.116164_b0110","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.neuropharm.2006.05.003","article-title":"Enhanced antinociceptive effects of morphine in histamine H2 receptor gene knockout mice","volume":"51","author":"Mobarakeh","year":"2006","journal-title":"Neuropharmacology"},{"issue":"2","key":"10.1016\/j.bcp.2024.116164_b0115","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.neures.2006.10.020","article-title":"Selective cognitive dysfunction in mice lacking histamine H1 and H2 receptors","volume":"57","author":"Dai","year":"2007","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.bcp.2024.116164_b0120","doi-asserted-by":"crossref","unstructured":"F. Meiler, J. Zumkehr, S. Klunker, B. R\u00fcckert, C.A. Akdis, M. Akdis. In vivo switch to IL-10-secreting T regulatory cells in high dose allergen exposure. J Exp Med. 2008 Nov 24;205(12):2887-98. https:\/\/doi.org\/10.1084\/jem.20080193. Epub 2008 Nov 10. PMID: 19001136; PMCID: PMC2585856.","DOI":"10.1084\/jem.20080193"},{"issue":"3","key":"10.1016\/j.bcp.2024.116164_b0125","doi-asserted-by":"crossref","first-page":"G532","DOI":"10.1152\/ajpgi.00138.2007","article-title":"Modulatory role of phosphoinositide 3-kinase in gastric acid secretion","volume":"293","author":"Mettler","year":"2007","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"issue":"7","key":"10.1016\/j.bcp.2024.116164_b0130","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1073\/pnas.89.7.2649","article-title":"Expression of a cloned rat histamine H2 receptor mediating inhibition of arachidonate release and activation of cAMP accumulation","volume":"89","author":"Traiffort","year":"1992","journal-title":"PNAS"},{"issue":"18","key":"10.1016\/j.bcp.2024.116164_b0135","doi-asserted-by":"crossref","first-page":"9739","DOI":"10.3390\/ijms22189739","article-title":"Label-free investigations on the G protein dependent signaling pathways of histamine receptors","volume":"22","author":"Seibel-Ehlert","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"18","key":"10.1016\/j.bcp.2024.116164_b0140","doi-asserted-by":"crossref","first-page":"10047","DOI":"10.3390\/ijms221810047","article-title":"Specific engineered G protein coupling to histamine receptors revealed from cellular assay experiments and accelerated molecular dynamics simulations","volume":"22","author":"H\u00f6ring","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.bcp.2024.116164_b0145","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1111\/j.1600-0625.2010.01133.x","article-title":"Histamine effect on melanocyte proliferation and vitiliginous keratinocyte survival","volume":"19","author":"Kim","year":"2010","journal-title":"Exp. Dermatol."},{"issue":"9","key":"10.1016\/j.bcp.2024.116164_b0150","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1017\/S1461145710001501","article-title":"Histamine facilitates consolidation of fear extinction","volume":"14","author":"Bonini","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"issue":"6","key":"10.1016\/j.bcp.2024.116164_b0155","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1095\/biolreprod.112.102905","article-title":"Proliferative effect of histamine on MA-10 Leydig tumor cells mediated through HRH2 activation, transient elevation in cAMP production, and increased extracellular signal-regulated kinase phosphorylation levels","volume":"87","author":"Pagotto","year":"2012","journal-title":"Biol. Reprod."},{"issue":"3","key":"10.1016\/j.bcp.2024.116164_b0160","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s00395-013-0342-4","article-title":"Histamine H2 receptor activation exacerbates myocardial ischemia\/reperfusion injury by disturbing mitochondrial and endothelial function","volume":"108","author":"Luo","year":"2013","journal-title":"Basic Res. Cardiol."},{"issue":"9","key":"10.1016\/j.bcp.2024.116164_b0165","first-page":"1998","article-title":"PI3K pathway is involved in ERK signaling cascade activation by histamine H2R agonist in HEK293T cells","volume":"1860","author":"Alonso","year":"2016","journal-title":"BBA"},{"issue":"1","key":"10.1016\/j.bcp.2024.116164_b0170","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1042\/BJ20131226","article-title":"Signal transduction mechanism of biased ligands at histamine H2 receptors","volume":"459","author":"Alonso","year":"2014","journal-title":"Biochem. J"},{"issue":"6","key":"10.1016\/j.bcp.2024.116164_b0175","first-page":"45","article-title":"Physiological implications of biased signaling at histamine H2 receptors","volume":"10","author":"Alonso","year":"2015","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.bcp.2024.116164_b0180","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.4155\/fmc-2021-0058","article-title":"Histamine H2 receptor radioligands: triumphs and challenges","volume":"13","author":"Pockes","year":"2021","journal-title":"Future Med. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2024.116164_b0185","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1124\/jpet.120.000063","article-title":"Characterization of stressed transgenic mice overexpressing H2-histamine receptors in the heart","volume":"374","author":"Gergs","year":"2020","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"12","key":"10.1016\/j.bcp.2024.116164_b0190","article-title":"The Roles of cardiovascular H2-histamine receptors under normal and pathophysiological conditions","volume":"20","author":"Neumann","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116164_b0195","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/164_2016_8","article-title":"Histamine H2 receptor in blood cells: a suitable target for the treatment of acute myeloid leukemia","volume":"241","author":"Monczor","year":"2017","journal-title":"Handb. Exp. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116164_b0200","doi-asserted-by":"crossref","unstructured":"Q. Ma, L.Jiang, H. Chen, D. An, Y. Ping, Y. Wang, H. Dai, X. Zhang, Y. Wang, Z. Chen, W. Hu. Histamine H2 receptor deficit in glutamatergic neurons contributes to the pathogenesis of schizophrenia. Proc Natl Acad Sci U S A. 2023 Feb 28;120(9):e2207003120. https:\/\/doi.org\/10.1073\/pnas.2207003120. Epub 2023 Feb 22. PMID: 36812204; PMCID: PMC9992765.","DOI":"10.1073\/pnas.2207003120"},{"key":"10.1016\/j.bcp.2024.116164_b0205","unstructured":"R.W. Brimblecombe, W.A. Duncan, G.J. Durant, C.R. Ganellin, M.E. Parsons, J.W. Black. The pharmacology of cimetidine, a new histamine H2-receptor antagonist. Br J Pharmacol. 1975 Mar;53(3):435P-436P. PMID: 236798; PMCID: PMC1666433."},{"key":"10.1016\/j.bcp.2024.116164_b0210","unstructured":"J. Bradshaw, R.T. Brittain, J.W. Clitherow, M.J. Daly, D. Jack, B.J. Price, R. Stables. Ranitidine (AH 19065): a new potent, selective histamine H2-receptor antagonist [proceedings]. Br J Pharmacol. 1979 Jul;66(3):464P. PMID: 43178; PMCID: PMC2043664."},{"issue":"10","key":"10.1016\/j.bcp.2024.116164_b0215","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1248\/bpb1978.15.561","article-title":"Comparative study of the H2-receptor antagonists cimetidine, ranitidine, famotidine and nizatidine on the rabbit stomach fundus and sigmoid colon","volume":"15","author":"Kounenis","year":"1992","journal-title":"J. Pharmacobiodyn."},{"key":"10.1016\/j.bcp.2024.116164_b0220","doi-asserted-by":"crossref","unstructured":"D.Y. Graham, History of helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer, World J. Gastroenterol. 2014 May 14;20(18):5191-204. https:\/\/doi.org\/10.3748\/wjg.v20.i18.5191. PMID: 24833849; PMCID: PMC4017034.","DOI":"10.3748\/wjg.v20.i18.5191"},{"issue":"4","key":"10.1016\/j.bcp.2024.116164_b0225","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.mcna.2016.03.009","article-title":"Pharmacologic therapies in gastrointestinal diseases","volume":"100","author":"Fox","year":"2016","journal-title":"Med. Clin. North Am."},{"key":"10.1016\/j.bcp.2024.116164_b0230","doi-asserted-by":"crossref","unstructured":"M.K. Joo, C.H. Park, J.S. Kim, J.M.Park, J.Y. Ahn, B.E. Lee, J.H. Lee, H.J. Yang, Y.K. Cho, C.S. Bang, B.J. Kim, H.K. Jung, B.W. Kim, Y.C. Lee. Korean College of Helicobacter Upper Gastrointestinal Research. Clinical Guidelines for Drug-Related Peptic Ulcer, 2020 Revised Edition. Gut Liver. 2020 Nov 15;14(6):707-726. https:\/\/doi.org\/10.5009\/gnl20246. PMID: 33191311; PMCID: PMC7667931.","DOI":"10.5009\/gnl20246"},{"issue":"1","key":"10.1016\/j.bcp.2024.116164_b0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/01.RES.58.1.1","article-title":"Histamine and cardiac arrhythmias","volume":"58","author":"Wolff","year":"1986","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.bcp.2024.116164_b0240","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1358\/mf.1999.21.2.529239","article-title":"Cardiac histamine receptors: their pharmacological consequences and signal transduction pathways","volume":"21","author":"Hattori","year":"1999","journal-title":"Methods Find. Exp. Clin. Pharmacol."},{"issue":"7","key":"10.1016\/j.bcp.2024.116164_b0245","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1042\/CS20130716","article-title":"Disruption of histamine H2 receptor slows heart failure progression through reducing myocardial apoptosis and fibrosis","volume":"127","author":"Zeng","year":"2014","journal-title":"Clin. Sci. (Lond.)"},{"issue":"13","key":"10.1016\/j.bcp.2024.116164_b0250","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.jacc.2016.01.045","article-title":"Histamine H2 receptor antagonists, left ventricular morphology, and heart failure risk: the MESA study","volume":"67","author":"Leary","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"issue":"10","key":"10.1016\/j.bcp.2024.116164_b0255","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2147\/CLEP.S162909","article-title":"Use of histamine H2 receptor antagonists and outcomes in patients with heart failure: a nationwide population-based cohort study","volume":"7","author":"Adelborg","year":"2018","journal-title":"Clin. Epidemiol."},{"issue":"14","key":"10.1016\/j.bcp.2024.116164_b0260","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1093\/eurjpc\/zwac122","article-title":"Histamine H2 receptor antagonist exposure was related to decreased all-cause mortality in critical ill patients with heart failure: a cohort study","volume":"29","author":"Huang","year":"2022","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.bcp.2024.116164_b0265","doi-asserted-by":"crossref","unstructured":"S.R. Larson, A.L. Vasbinder, K.W. Reding, P.J. Leary, K.R. Branch, A.H. Shadyab, K.C. Johnson, B. Haring, R. Wallace. Histamine H2 receptor antagonists and heart failure risk in postmenopausal women: the women's health initiative. J Am Heart Assoc. 2022 Mar;11(5):e024270. https:\/\/doi.org\/10.1161\/JAHA.121.024270. Epub 2022 Feb 22. PMID: 35191329; PMCID: PMC9075064.","DOI":"10.1161\/JAHA.121.024270"},{"key":"10.1016\/j.bcp.2024.116164_b0270","doi-asserted-by":"crossref","unstructured":"Z. Fedorowicz, E.J. van Zuuren, N. Hu. Histamine H2-receptor antagonists for urticaria. Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD008596. https:\/\/doi.org\/10.1002\/14651858.CD008596.pub2. PMID: 22419335; PMCID: PMC7390502.","DOI":"10.1002\/14651858.CD008596.pub2"},{"issue":"3","key":"10.1016\/j.bcp.2024.116164_b0275","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/all.15090","article-title":"The international EAACI\/GA2LEN\/EuroGuiDerm\/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria","volume":"77","author":"Zuberbier","year":"2022","journal-title":"Allergy"},{"issue":"3","key":"10.1016\/j.bcp.2024.116164_b0280","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/0163-7258(95)00006-3","article-title":"Molecular pharmacological aspects of histamine receptors","volume":"66","author":"Leurs","year":"1995","journal-title":"Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.bcp.2024.116164_b0285","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1124\/mol.64.2.512","article-title":"Tiotidine, a histamine H2 receptor inverse agonist that binds with high affinity to an inactive G-protein-coupled form of the receptor. experimental support for the cubic ternary complex model","volume":"64","author":"Monczor","year":"2003","journal-title":"Mol. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2024.116164_b0290","doi-asserted-by":"crossref","first-page":"867","DOI":"10.2217\/pgs.09.26","article-title":"Histamine pharmacogenomics","volume":"10","author":"Garc\u00eda-Mart\u00edn","year":"2009","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.bcp.2024.116164_b0295","doi-asserted-by":"crossref","unstructured":"S. Micallef, A. Sasse. (2016). Genetic polymorphisms in the histamine receptor family. In: Blandina, P, Passani, M (eds) Histamine Receptors. The Receptors, vol 28. Humana, Cham. https:\/\/doi.org\/10.1007\/978-3-319-40308-3_2.","DOI":"10.1007\/978-3-319-40308-3_2"},{"issue":"7","key":"10.1016\/j.bcp.2024.116164_b0300","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1097\/00001756-199605170-00015","article-title":"Allelic variations of the human histamine H2 receptor gene","volume":"7","author":"Orange","year":"1996","journal-title":"Neuroreport"},{"issue":"6","key":"10.1016\/j.bcp.2024.116164_b0305","first-page":"466","article-title":"Individuals with schizophrenia have an increased incidence of the H2R649G allele for the histamine H2 receptor gene","volume":"1","author":"Orange","year":"1996","journal-title":"Mol. Psychiatry"},{"issue":"2","key":"10.1016\/j.bcp.2024.116164_b0310","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/sj.mp.4000664","article-title":"Histamine H2 receptor gene variants: lack of association with schizophrenia","volume":"5","author":"Ito","year":"2000","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.bcp.2024.116164_b0315","doi-asserted-by":"crossref","unstructured":"M.M. Welsh, M.R. Karagas, J.K. Kuriger, A. Houseman, S.K. Spencer, A.E. Perry, H.H. Nelson. Genetic determinants of UV-susceptibility in non-melanoma skin cancer. PLoS One. 2011;6(7):e20019. https:\/\/doi.org\/10.1371\/journal.pone.0020019. Epub 2011 Jul 8. PMID: 21760883; PMCID: PMC3132750.","DOI":"10.1371\/journal.pone.0020019"},{"key":"10.1016\/j.bcp.2024.116164_b0320","doi-asserted-by":"crossref","unstructured":"M. Whirl-Carrillo, R. Huddart, L. Gong, K. Sangkuhl, C.F. Thorn, R. Whaley, T.E. Klein. An evidence-based framework for evaluating pharmacogenomics knowledge for personalized medicine. Clin Pharmacol Ther. 2021 Sep;110(3):563-572. https:\/\/doi.org\/10.1002\/cpt.2350. https:\/\/www.pharmgkb.org\/variant\/PA166156782\/overview. Accessed february 29, 2024.","DOI":"10.1002\/cpt.2350"},{"key":"10.1016\/j.bcp.2024.116164_b0325","unstructured":"National Library of Medicine. dbSNP Short Genetic Variations. https:\/\/www.ncbi.nlm.nih.gov\/snp\/rs2067474#frequency_tab. Accessed february 29, 2024."},{"key":"10.1016\/j.bcp.2024.116164_b0330","doi-asserted-by":"crossref","unstructured":"E. Garc\u00eda-Mart\u00edn, P. Ayuso, A. Luengo, C. Mart\u00ednez, J.A. Ag\u00fandez, Genetic variability of histamine receptors in patients with Parkinson\u2019s disease, BMC Med. Genet. 17 (9) (2008 Mar) 15, https:\/\/doi.org\/10.1186\/1471-2350-9-15. PMID: 18366640; PMCID: PMC2292154.","DOI":"10.1186\/1471-2350-9-15"},{"issue":"3","key":"10.1016\/j.bcp.2024.116164_b0335","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0304-3940(02)00178-7","article-title":"Investigation of promoter variants of the histamine 1 and 2 receptors in schizophrenia and clozapine response","volume":"333","author":"Mancama","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.bcp.2024.116164_b0340","doi-asserted-by":"crossref","unstructured":"J. Schumacher, T.G. Schulze, T.F. Wienker, M. Rietschel, M.M. N\u00f6then, Pharmacogenetics of the clozapine response, Lancet 356 (9228) (2000 Aug 5) 506\u2013507 PMID: 10981913, https:\/\/doi.org\/10.1016\/s0140-6736(05)74176-3.","DOI":"10.1016\/S0140-6736(05)74176-3"},{"key":"10.1016\/j.bcp.2024.116164_b0345","doi-asserted-by":"crossref","unstructured":"G.H. He, W.K. Cai, J.B. Zhang, C.Y. Ma, F. Yan, J. Lu, G.L. Xu. Associations of polymorphisms in HRH2, HRH3, DAO, and HNMT genes with risk of chronic heart failure. Biomed Res Int. 2016;2016:1208476. https:\/\/doi.org\/10.1155\/2016\/1208476. Epub 2016 Feb 17. PMID: 26989676; PMCID: PMC4773518.","DOI":"10.1155\/2016\/1208476"},{"key":"10.1016\/j.bcp.2024.116164_b0350","doi-asserted-by":"crossref","unstructured":"P.J. Leary, R.A. Kronmal, D.A. Bluemke, P.M. Buttrick, K.L. Jones, D.P. Kao, S.M. Kawut, E.V. Krieger. Histamine H2 receptor polymorphisms, myocardial transcripts, and heart failure (from the multi-ethnic study of atherosclerosis and beta-blocker effect on remodeling and gene expression trial). Am J Cardiol. 2018 Jan 15;121(2):256-261. https:\/\/doi.org\/10.1016\/j.amjcard.2017.10.016. Epub 2017 Oct 20. PMID: 29191567; PMCID: PMC5742297.","DOI":"10.1016\/j.amjcard.2017.10.016"},{"issue":"2","key":"10.1016\/j.bcp.2024.116164_b0355","first-page":"139","article-title":"Effects of -1018G>A polymorphism of HRH2 (rs2607474) on the severity of gastric mucosal atrophy","volume":"21","author":"Yamada","year":"2012","journal-title":"J. Gastrointestin. Liver Dis."},{"issue":"2","key":"10.1016\/j.bcp.2024.116164_b0360","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3892\/ijo.2012.1482","article-title":"Association between common genetic variant of HRH2 and gastric cancer risk","volume":"41","author":"Arisawa","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bcp.2024.116164_b0365","doi-asserted-by":"crossref","unstructured":"W.K. Cai, J.B. Zhang, N.M. Wang, Y.L. Wang, C.H. Zhao, J. Lu, G.H. He. Lack of association between rs2067474 polymorphism in histamine receptor H2 gene and breast cancer in chinese han population. ScientificWorldJournal. 2015;2015:545292. https:\/\/doi.org\/10.1155\/2015\/545292. Epub 2015 Apr 2. PMID: 25922853; PMCID: PMC4398955.","DOI":"10.1155\/2015\/545292"},{"issue":"12","key":"10.1016\/j.bcp.2024.116164_b0370","doi-asserted-by":"crossref","first-page":"e0189521.","DOI":"10.1371\/journal.pone.0189521","article-title":"Effects of genetic polymorphisms on the OCT1 and OCT2-mediated uptake of ranitidine","volume":"12","author":"Meyer","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.bcp.2024.116164_b0375","doi-asserted-by":"crossref","unstructured":"T. Akiyoshi, T. Saito, S. Murase, M. Miyazaki, N. Murayama, H. Yamazaki, F.P. Guengerich, K. Nakamura, K. Yamamoto, H. Ohtani. Comparison of the inhibitory profiles of itraconazole and cimetidine in cytochrome P450 3A4 genetic variants. Drug Metab Dispos. 2011 Apr;39(4):724-8. https:\/\/doi.org\/10.1124\/dmd.110.036780. Epub 2015 Apr 2. PMID: 25922853; PMCID: PMC4398955.","DOI":"10.1124\/dmd.110.036780"},{"issue":"2","key":"10.1016\/j.bcp.2024.116164_b0380","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1189\/jlb.3RI0413-217RR","article-title":"Tumor formation and antitumor immunity; the overlooked significance of histamine","volume":"96","author":"Falus","year":"2014","journal-title":"J. Leukoc. Biol."},{"issue":"3","key":"10.1016\/j.bcp.2024.116164_b0385","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1046\/j.1523-1747.2000.00054.x","article-title":"Histidine decarboxylase expression in human melanoma","volume":"115","author":"Haak-Frendscho","year":"2000","journal-title":"J, Invest. Dermatol."},{"issue":"3","key":"10.1016\/j.bcp.2024.116164_b0390","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.breast.2004.06.012","article-title":"Concentration of histamine in serum and tissues of the primary ductal breast cancers in women","volume":"14","author":"Sieja","year":"2005","journal-title":"Breast"},{"issue":"3","key":"10.1016\/j.bcp.2024.116164_b0395","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/bjc.1983.55","article-title":"Decreased blood histamine levels in patients with solid malignant tumours","volume":"47","author":"Burtin","year":"1983","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.bcp.2024.116164_b0400","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/BF00398182","article-title":"Blood histamine and solid malignant tumors","volume":"114","author":"Moriarty","year":"1988","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116164_b0405","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bcp.2024.116164_b0410","unstructured":"G. Cricco, N. Mohamad, G. Martin. Insights into histamine role in cell migration and matrix remodeling: special focus on tumor biology. In Histamines: Synthesis, Pharmacology and Clinical Uses. Advances in Medicine and Biology. Volume 54 (pp.29-50) Edition: Nueva York, USA Chapter: 2 Publisher: Nova Science Publishers. Editors: Leon V. Berhardt. https:\/\/novapublishers.com\/shop\/advances-in-medicine-and-biology-volume-54\/."},{"issue":"3","key":"10.1016\/j.bcp.2024.116164_b0415","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3390\/biom11030415","article-title":"Histamine, metabolic remodelling and angiogenesis: a systems level approach","volume":"11","author":"Moya-Garc\u00eda","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.bcp.2024.116164_b0420","doi-asserted-by":"crossref","unstructured":"M.P. Sarasola, M.A. T\u00e1quez Delgado, M.B. Nicoud, V.A. Medina. Histamine in cancer immunology and immunotherapy. Current status and new perspectives. Pharmacol Res Perspect. 2021 Oct;9(5):e00778. https:\/\/doi.org\/10.1002\/prp2.778. PMID: 34609067; PMCID: PMC8491460.","DOI":"10.1002\/prp2.778"},{"issue":"1","key":"10.1016\/j.bcp.2024.116164_b0425","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1006\/scbi.2000.0303","article-title":"Histamine as an autocrine growth factor: an unusual role for a widespread mediator","volume":"10","author":"Rivera","year":"2000","journal-title":"Semin. Cancer Biol."},{"issue":"3","key":"10.1016\/j.bcp.2024.116164_b0430","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1254\/jphs.93.321","article-title":"Roxatidine- and cimetidine-induced angiogenesis inhibition suppresses growth of colon cancer implants in syngeneic mice","volume":"93","author":"Tomita","year":"2003","journal-title":"J. Pharmacol. Sci."},{"issue":"11","key":"10.1016\/j.bcp.2024.116164_b0435","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.4161\/cbt.5.11.3273","article-title":"Histamine-mediated signaling processes in human malignant mammary cells","volume":"5","author":"Medina","year":"2006","journal-title":"Cancer Biol. Ther."},{"issue":"3","key":"10.1016\/j.bcp.2024.116164_b0440","doi-asserted-by":"crossref","first-page":"146","DOI":"10.2174\/187152810792231869","article-title":"Histamine and histamine receptor antagonists in cancer biology","volume":"9","author":"Blaya","year":"2010","journal-title":"Inflamm. Allergy Drug Targets"},{"issue":"6","key":"10.1016\/j.bcp.2024.116164_b0445","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.ejca.2013.12.025","article-title":"Activation of histamine H4 receptors decreases epithelial-to-mesenchymal transition progress by inhibiting transforming growth factor-\u03b21 signalling pathway in non-small cell lung cancer","volume":"50","author":"Cai","year":"2014","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"10.1016\/j.bcp.2024.116164_b0450","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/CMR.0b013e328347ee53","article-title":"Role of H4 receptor in histamine-mediated responses in human melanoma","volume":"21","author":"Massari","year":"2011","journal-title":"Melanoma Res."},{"key":"10.1016\/j.bcp.2024.116164_b0455","doi-asserted-by":"crossref","unstructured":"L. Kennedy, L. Hargrove, J. Demieville, W. Karstens, H. Jones, S. DeMorrow, F. Meng, P. Invernizzi. Blocking H1\/H2 histamine receptors inhibits damage\/fibrosis in Mdr2-\/- mice and human cholangiocarcinoma tumorigenesis. Hepatology. 2018 Sep;68(3):1042-1056. https:\/\/doi.org\/10.1002\/hep.29898. Epub 2018 Jun 1. Erratum in: Hepatology. 2022 Dec;76(6):1898. PMID: 29601088; PMCID: PMC6165706.","DOI":"10.1002\/hep.29898"},{"key":"10.1016\/j.bcp.2024.116164_b0460","doi-asserted-by":"crossref","unstructured":"J. Zhao, Y. Hou, C. Yin, J. Hu, T. Gao, X. Huang, X. Zhang, J. Xing, J. An, S. Wan, J. Li. Upregulation of histamine receptor H1 promotes tumor progression and contributes to poor prognosis in hepatocellular carcinoma. Oncogene. 2020 Feb;39(8):1724-1738. https:\/\/doi.org\/10.1038\/s41388-019-1093-y. Epub 2019 Nov 18. PMID: 31740780; PMCID: PMC7033043.","DOI":"10.1038\/s41388-019-1093-y"},{"key":"10.1016\/j.bcp.2024.116164_b0465","doi-asserted-by":"crossref","unstructured":"Y.Y. Zhao, J. Jia, J.J. Zhang, Y.P. Xun, S.J. Xie, J.F. Liang. Inhibition of histamine receptor H3 suppresses the growth and metastasis of human non-small cell lung cancer cells via inhibiting PI3K\/Akt\/mTOR and MEK\/ERK signaling pathways and blocking EMT. Acta Pharmacol Sin. 2021 Aug;42(8):1288-1297. https:\/\/doi.org\/10.1038\/s41401-020-00548-6. Epub 2020 Nov 6. PMID: 33159174; PMCID: PMC8285495.","DOI":"10.1038\/s41401-020-00548-6"},{"key":"10.1016\/j.bcp.2024.116164_b0470","unstructured":"HUGO Gene Nomenclature Commitee https:\/\/www.genenames.org\/. Accessed August 8, 2023."},{"issue":"8","key":"10.1016\/j.bcp.2024.116164_b0475","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: A portal for facilitating tumor subgroup gene expression and survival analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"issue":"5","key":"10.1016\/j.bcp.2024.116164_b0480","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","article-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","volume":"2","author":"Cerami","year":"2012","journal-title":"Cancer Discov."},{"key":"10.1016\/j.bcp.2024.116164_b0485","doi-asserted-by":"crossref","unstructured":"J. Gao, B.A. Aksoy, U. Dogrusoz, G. Dresdner, B. Gross, S.O. Sumer, Y. Sun, A. Jacobsen. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013 Apr 2;6(269):pl1. https:\/\/doi.org\/10.1126\/scisignal.2004088. PMID: 23550210; PMCID: PMC4160307.","DOI":"10.1126\/scisignal.2004088"},{"key":"10.1016\/j.bcp.2024.116164_b0490","unstructured":"Firebrowse http:\/\/firebrowse.org\/. Accessed July 4, 2023."},{"issue":"8121","key":"10.1016\/j.bcp.2024.116164_b0495","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/S0140-6736(79)91306-0","article-title":"Antitumour effect of cimetidine","volume":"1","author":"Armitage","year":"1979","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bcp.2024.116164_b0500","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0309-1651(78)90043-7","article-title":"Stimulation of cell proliferation by histamine H2 receptors in dimethylhdrazine-induced adenocarcinomata","volume":"2","author":"Tutton","year":"1978","journal-title":"Cell Biol. Int. Rep."},{"issue":"8","key":"10.1016\/j.bcp.2024.116164_b0505","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1136\/gut.34.8.1091","article-title":"Effect of histamine on the growth of human gastrointestinal tumours: reversal by cimetidine","volume":"34","author":"Watson","year":"1993","journal-title":"Gut"},{"issue":"1\u20132","key":"10.1016\/j.bcp.2024.116164_b0510","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF02005757","article-title":"Histamine as an autocrine growth factor in experimental mammary carcinomas","volume":"43","author":"Cricco","year":"1994","journal-title":"Agents Actions"},{"issue":"2","key":"10.1016\/j.bcp.2024.116164_b0515","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/00008390-199604000-00003","article-title":"In vitro effect of histamine and histamine H1 and H2 receptor antagonists on cellular proliferation of human malignant melanoma cell lines","volume":"6","author":"Reynolds","year":"1996","journal-title":"Melanoma Res."},{"issue":"11","key":"10.1016\/j.bcp.2024.116164_b0520","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1136\/gut.35.11.1632","article-title":"Cimetidine inhibits in vivo growth of human colon cancer and reverses histamine stimulated in vitro and in vivo growth","volume":"35","author":"Adams","year":"1994","journal-title":"Gut"},{"issue":"3","key":"10.1016\/j.bcp.2024.116164_b0525","first-page":"673","article-title":"Cimetidine induces apoptosis of human salivary gland tumor cells","volume":"17","author":"Fukuda","year":"2007","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.bcp.2024.116164_b0530","first-page":"693","article-title":"Cimetidine induces apoptosis in gastric cancer cells in vitro and inhibits tumor growth in vivo","volume":"23","author":"Jiang","year":"2010","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bcp.2024.116164_b0535","doi-asserted-by":"crossref","unstructured":"P. Dana, K. Vaeteewoottacharn, R. Kariya, K. Matsuda, S. Wongkham, S. Okada. Repurposing cimetidine for cholangiocarcinoma: Antitumor effects in vitro and in vivo. Oncol Lett. 2017 Mar;13(3):1432-1436. https:\/\/doi.org\/10.3892\/ol.2017.5563. Epub 2017 Jan 2. PMID: 28454273; PMCID: PMC5403332.","DOI":"10.3892\/ol.2017.5563"},{"issue":"3","key":"10.1016\/j.bcp.2024.116164_b0540","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00008390-200206000-00006","article-title":"Cimetidine and a tamoxifen derivate reduce tumour formation in SCID mice xenotransplanted with a human melanoma cell line","volume":"12","author":"Szincs\u00e1k","year":"2002","journal-title":"Melanoma Res."},{"issue":"1\u20133","key":"10.1016\/j.bcp.2024.116164_b0545","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1163\/156856005774423917","article-title":"Histamine regulates growth of malignant melanoma implants via H2 receptors in mice","volume":"13","author":"Tomita","year":"2005","journal-title":"Inflammopharmacology"},{"issue":"7","key":"10.1016\/j.bcp.2024.116164_b0550","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1151591","article-title":"Ranitidine modifies myeloid cell populations and inhibits breast tumor development and spread in mice","volume":"5","author":"Vila-Leahey","year":"2016","journal-title":"Oncoimmunology."},{"issue":"16","key":"10.1016\/j.bcp.2024.116164_b0555","doi-asserted-by":"crossref","first-page":"R921","DOI":"10.1016\/j.cub.2020.06.081","article-title":"The tumor microenvironment","volume":"30","author":"Anderson","year":"2020","journal-title":"Curr. Biol."},{"issue":"10","key":"10.1016\/j.bcp.2024.116164_b0560","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1080\/21645515.2016.1191719","article-title":"Cimetidine down-regulates stability of Foxp3 protein via Stub1 in Treg cells","volume":"12","author":"Zhang","year":"2016","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.bcp.2024.116164_b0565","doi-asserted-by":"crossref","unstructured":"X.D. Yang, W. Ai, S. Asfaha, G. Bhagat, R.A. Friedman, G. Jin, H. Park, B. Shykind, T.G. Diacovo, A. Falus, T.C. Wang. Histamine deficiency promotes inflammation-associated carcinogenesis through reduced myeloid maturation and accumulation of CD11b+Ly6G+ immature myeloid cells. Nat Med. 2011 Jan;17(1):87-95. https:\/\/doi.org\/10.1038\/nm.2278. Epub 2010 Dec 19. PMID: 21170045; PMCID: PMC3075560.","DOI":"10.1038\/nm.2278"},{"issue":"2","key":"10.1016\/j.bcp.2024.116164_b0570","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/imm.12036","article-title":"The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells","volume":"138","author":"Lindau","year":"2013","journal-title":"Immunology"},{"issue":"8","key":"10.1016\/j.bcp.2024.116164_b0575","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1038\/sj.bjc.6600233","article-title":"Cimetidine modulates the antigen presenting capacity of dendritic cells from colorectal cancer patients","volume":"86","author":"Kubota","year":"2002","journal-title":"Br. J. Cancer"},{"issue":"6854","key":"10.1016\/j.bcp.2024.116164_b0580","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/35096564","article-title":"Histamine regulates T-cell and antibody responses by differential expression of H1 and H2 receptors","volume":"413","author":"Jutel","year":"2001","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.bcp.2024.116164_b0585","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1096\/fj.02-1008com","article-title":"Histamine enhances TGF-beta1-mediated suppression of Th2 responses","volume":"17","author":"Kunzmann","year":"2003","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2024.116164_b0590","doi-asserted-by":"crossref","unstructured":"X. Xie, S. Geng, H. Liu, C. Li, Y. Yang, B. Wang. Cimetidine synergizes with Praziquantel to enhance the immune response of HBV DNA vaccine via activating cytotoxic CD8(+) T cell. Hum Vaccin Immunother. 2014;10(6):1688-99. https:\/\/doi.org\/10.4161\/hv.28517. Epub 2014 Mar 18. PMID: 24643207; PMCID: PMC5396244.","DOI":"10.4161\/hv.28517"},{"key":"10.1016\/j.bcp.2024.116164_b0595","doi-asserted-by":"crossref","unstructured":"N. Flamand, H. Plante, S. Picard, M. Laviolette, P. Borgeat. Histamine-induced inhibition of leukotriene biosynthesis in human neutrophils: involvement of the H2 receptor and cAMP. Br J Pharmacol. 2004 Feb;141(4):552-61. https:\/\/doi.org\/10.1038\/sj.bjp.0705654. Epub 2004 Jan 26. PMID: 14744809; PMCID: PMC1574237.","DOI":"10.1038\/sj.bjp.0705654"},{"issue":"2","key":"10.1016\/j.bcp.2024.116164_b0600","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.bcp.2012.04.004","article-title":"Incomplete activation of human eosinophils via the histamine H4-receptor: evidence for ligand-specific receptor conformations","volume":"84","author":"Reher","year":"2012","journal-title":"Biochem. Pharmacol."},{"issue":"3 Suppl 7","key":"10.1016\/j.bcp.2024.116164_b0605","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1053\/sonc.2002.33081","article-title":"Histamine in cancer immunotherapy: a preclinical background","volume":"29","author":"Hellstrand","year":"2002","journal-title":"Semin. Oncol."},{"issue":"2","key":"10.1016\/j.bcp.2024.116164_b0610","doi-asserted-by":"crossref","first-page":"430","DOI":"10.2741\/3936","article-title":"H\u2084 receptors in mast cells and basophils: a new therapeutic target for allergy?","volume":"17","author":"Gibbs","year":"2012","journal-title":"Front Biosci (Landmark Ed)."},{"key":"10.1016\/j.bcp.2024.116164_b0615","doi-asserted-by":"crossref","unstructured":"G. Varricchi, A. de Paulis, G. Marone, S.J. Galli, Future Needs in Mast Cell Biology, Int. J. Mol. Sci. 20 (18) (2019 Sep 6) 4397, https:\/\/doi.org\/10.3390\/ijms20184397. PMID: 31500217; PMCID: PMC6769913.","DOI":"10.3390\/ijms20184397"},{"key":"10.1016\/j.bcp.2024.116164_b0620","doi-asserted-by":"crossref","unstructured":"X. Guo, M. Sun, P. Yang, X. Meng, R. Liu. Role of mast cells activation in the tumor immune microenvironment and immunotherapy of cancers. Eur J Pharmacol. 2023 Oct 16;960:176103. https:\/\/doi.org\/10.1016\/j.ejphar.2023.176103. Epub ahead of print. PMID: 37852570.","DOI":"10.1016\/j.ejphar.2023.176103"},{"issue":"1","key":"10.1016\/j.bcp.2024.116164_b0625","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1006\/clin.1994.1174","article-title":"Histamine inhibits immunoglobulin production via histamine H2 receptors without affecting cell growth in human B cells","volume":"73","author":"Fujimoto","year":"1994","journal-title":"Clin. Immunol. Immunopathol."},{"issue":"5","key":"10.1016\/j.bcp.2024.116164_b0630","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ejps.2011.02.004","article-title":"Cimetidine: an anticancer drug?","volume":"42","author":"Kubecova","year":"2011","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.bcp.2024.116164_b0635","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.intimp.2019.02.026","article-title":"Immunomodulatory properties of cimetidine: Its therapeutic potentials for treatment of immune-related diseases","volume":"70","author":"Jafarzadeh","year":"2019","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2024.116164_b0640","doi-asserted-by":"crossref","unstructured":"P.L. Nguyen, J. Cho, Pathophysiological Roles of Histamine Receptors in Cancer Progression: Implications and Perspectives as Potential Molecular Targets, Biomolecules 11 (8) (2021 Aug 18) 1232, https:\/\/doi.org\/10.3390\/biom11081232. PMID: 34439898; PMCID: PMC8392479.","DOI":"10.3390\/biom11081232"},{"issue":"1","key":"10.1016\/j.bcp.2024.116164_b0645","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.jaci.2013.01.013","article-title":"Histamine receptor 2 modifies dendritic cell responses to microbial ligands","volume":"132","author":"Frei","year":"2013","journal-title":"J. Allergy Clin. Immunol."},{"issue":"7","key":"10.1016\/j.bcp.2024.116164_b0650","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1097\/MIB.0000000000000825","article-title":"Histamine receptor 2 is required to suppress innate immune responses to bacterial ligands in patients with inflammatory bowel disease","volume":"22","author":"Smolinska","year":"2016","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.bcp.2024.116164_b0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109729","article-title":"Ranitidine as an adjuvant regulates macrophage polarization and activates CTLs through the PI3K-Akt2 signaling pathway","volume":"116","author":"Li","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.bcp.2024.116164_b0660","unstructured":"K. Norrby. Evidence of a dual role of endogenous histamine in angiogenesis. Int J Exp Pathol. 1995 Apr;76(2):87-92. PMID: 7540412; PMCID: PMC1997159."},{"issue":"2","key":"10.1016\/j.bcp.2024.116164_b0665","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001710","article-title":"Histamine causes an imbalance between pro-angiogenic and anti-angiogenic factors in the retinal pigment epithelium of diabetic retina via H4 receptor\/p38 MAPK axis","volume":"8","author":"Lee","year":"2020","journal-title":"BMJ Open Diabetes Res. Care"},{"issue":"4","key":"10.1016\/j.bcp.2024.116164_b0670","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jphs.2023.02.006","article-title":"Histamine promotes angiogenesis through a histamine H1 receptor-PKC-VEGF-mediated pathway in human endothelial cells","volume":"151","author":"Hatipoglu","year":"2023","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.bcp.2024.116164_b0675","doi-asserted-by":"crossref","unstructured":"L. Qin, D. Zhao, J. Xu, X. Ren, E.F. Terwilliger, S. Parangi, J. Lawler, H.F. Dvorak, H. Zeng. The vascular permeabilizing factors histamine and serotonin induce angiogenesis through TR3\/Nur77 and subsequently truncate it through thrombospondin-1. Blood. 2013 Mar 14;121(11):2154-64. https:\/\/doi.org\/10.1182\/blood-2012-07-443903. Epub 2013 Jan 11. PMID: 23315169; PMCID: PMC3596973.","DOI":"10.1182\/blood-2012-07-443903"},{"issue":"7","key":"10.1016\/j.bcp.2024.116164_b0680","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/sj.bjp.0704372","article-title":"Enhancement by histamine of vascular endothelial growth factor production in granulation tissue via H(2) receptors","volume":"134","author":"Ghosh","year":"2001","journal-title":"Br. J. Pharmacol."},{"issue":"8","key":"10.1016\/j.bcp.2024.116164_b0685","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1084\/jem.20011782","article-title":"Defective angiogenesis in the inflammatory granulation tissue in histidine decarboxylase-deficient mice but not in mast cell-deficient mice","volume":"195","author":"Ghosh","year":"2002","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.bcp.2024.116164_b0690","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3892\/or_00000401","article-title":"Anti-tumor effect of cimetidine via inhibiting angiogenesis factors in N-butyl-N-(4-hydroxybutyl) nitrosamine-induced mouse and rat bladder carcinogenesis","volume":"22","author":"Chihara","year":"2009","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bcp.2024.116164_b0695","doi-asserted-by":"crossref","unstructured":"T. Natori, M. Sata, R. Nagai, M. Makuuchi. Cimetidine inhibits angiogenesis and suppresses tumor growth. Biomed Pharmacother. 2005 Jan-Feb;59(1-2):56-60. https:\/\/doi.org\/10.1016\/j.biopha.2004.05.018. Epub 2005 Jan 26. PMID: 15740937.","DOI":"10.1016\/j.biopha.2004.05.018"},{"issue":"14","key":"10.1016\/j.bcp.2024.116164_b0700","first-page":"3978","article-title":"Cimetidine inhibits cancer cell adhesion to endothelial cells and prevents metastasis by blocking E-selectin expression","volume":"60","author":"Kobayashi","year":"2000","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.bcp.2024.116164_b0705","first-page":"537","article-title":"Cimetidine inhibits the adhesion of gastric cancer cells expressing high levels of sialyl Lewis x in human vascular endothelial cells by blocking E-selectin expression","volume":"27","author":"Liu","year":"2011","journal-title":"Int. J. Mol. Med."},{"issue":"4","key":"10.1016\/j.bcp.2024.116164_b0710","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00280-016-3006-x","article-title":"Inhibition of E-selectin expression on the surface of endothelial cells inhibits hepatocellular carcinoma growth by preventing tumor angiogenesis","volume":"77","author":"Borentain","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116164_b0715","doi-asserted-by":"crossref","unstructured":"R. Coppo, F. Orso, F. Virga, A. Dalmasso, D. Baruffaldi, L. Nie, F. Clapero, D. Dettori, L. Quirico, E. Grassi. ESDN inhibits melanoma progression by blocking E-selectin expression in endothelial cells via STAT3. Cancer Lett. 2021 Jul 10;510:13-23. https:\/\/doi.org\/10.1016\/j.canlet.2021.04.005. Epub 2021 Apr 13. PMID: 33862151; PMCID: PMC8581997.","DOI":"10.1016\/j.canlet.2021.04.005"},{"issue":"6","key":"10.1016\/j.bcp.2024.116164_b0720","first-page":"1293","article-title":"Increase in E-selectin expression in umbilical vein endothelial cells by anticancer drugs and inhibition by cimetidine","volume":"22","author":"Kawase","year":"2009","journal-title":"Oncol. Rep."},{"issue":"8","key":"10.1016\/j.bcp.2024.116164_b0725","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1186\/1471-2407-8-376","article-title":"Cimetidine inhibits salivary gland tumor cell adhesion to neural cells and induces apoptosis by blocking NCAM expression","volume":"18","author":"Fukuda","year":"2008","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.bcp.2024.116164_b0730","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3171\/jns.2005.102.4.0706","article-title":"Combined cimetidine and temozolomide, compared with temozolomide alone: significant increases in survival in nude mice bearing U373 human glioblastoma multiforme orthotopic xenografts","volume":"102","author":"Lefranc","year":"2005","journal-title":"J. Neurosurg."},{"issue":"1","key":"10.1016\/j.bcp.2024.116164_b0735","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1349-7006.2010.01756.x","article-title":"Phase-II trial of combination treatment of interferon-\u03b1, cimetidine, cyclooxygenase-2 inhibitor and renin-angiotensin-system inhibitor (I-CCA therapy) for advanced renal cell carcinoma","volume":"102","author":"Tatokoro","year":"2011","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bcp.2024.116164_b0740","doi-asserted-by":"crossref","unstructured":"O. Hemminki, N. Perlis, J. Bjorklund, A. Finelli, A.R. Zlotta, A. Hemminki, Treatment of advanced renal cell carcinoma: immunotherapies have demonstrated overall survival benefits while targeted therapies have not, Eur Urol Open Sci. 2020 Nov 28;22:61-73. https:\/\/doi.org\/10.1016\/j.euros.2020.11.003. PMID: 34337479; PMCID: PMC8317793.","DOI":"10.1016\/j.euros.2020.11.003"},{"issue":"7","key":"10.1016\/j.bcp.2024.116164_b0745","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/sj.bjc.6602768","article-title":"Two randomised phase II trials of subcutaneous interleukin-2 and histamine dihydrochloride in patients with metastatic renal cell carcinoma","volume":"93","author":"Donskov","year":"2005","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.bcp.2024.116164_b0750","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1038\/sj.bjc.6602937","article-title":"Monocytes and neutrophils as 'bad guys' for the outcome of interleukin-2 with and without histamine in metastatic renal cell carcinoma\u2013results from a randomised phase II trial","volume":"94","author":"Donskov","year":"2006","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.bcp.2024.116164_b0755","first-page":"487","article-title":"Continuous infusion interleukin-2 and antihistamines in metastatic kidney cancer","volume":"20","author":"Walker","year":"2005","journal-title":"Cancer Biother. Radiopharm."},{"issue":"4","key":"10.1016\/j.bcp.2024.116164_b0760","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4103\/0019-509X.19203","article-title":"Effect of preoperative short course famotidine on TILs and survival in breast cancer","volume":"42","author":"Parshad","year":"2005","journal-title":"Indian J. Cancer"},{"issue":"2","key":"10.1016\/j.bcp.2024.116164_b0765","first-page":"377","article-title":"The effect of cimetidine on natural killer activity of peripheral blood lymphocytes of patients with ovarian carcinoma","volume":"15","author":"Kikuchi","year":"1985","journal-title":"Jpn. J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.bcp.2024.116164_b0770","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/0277-5379(88)90126-5","article-title":"Effects of cimetidine on interleukin-2 production by peripheral blood lymphocytes in advanced ovarian carcinoma","volume":"24","author":"Kikuchi","year":"1988","journal-title":"Eur. J. Cancer Clin. Oncol."},{"issue":"5","key":"10.1016\/j.bcp.2024.116164_b0775","first-page":"515","article-title":"Continuous infusion interleukin-2 and famotidine in metastatic kidney cancer","volume":"21","author":"Quan","year":"2006","journal-title":"Cancer Biother. Radiopharm."},{"issue":"1","key":"10.1016\/j.bcp.2024.116164_b0780","first-page":"108","article-title":"Low-dose cyclophosphamide and continuous-infusion interleukin-2 with famotidine in previously treated metastatic melanoma or kidney cancer","volume":"23","author":"Quan","year":"2008","journal-title":"Cancer Biother. Radiopharm."},{"issue":"1","key":"10.1016\/j.bcp.2024.116164_b0785","first-page":"65","article-title":"Pulse interleukin-2 with famotidine induces CD56+ lymphocytes in the peripheral blood of patients with metastatic melanoma or kidney cancer","volume":"26","author":"Quan","year":"2011","journal-title":"Cancer Biother. Radiopharm."},{"issue":"2","key":"10.1016\/j.bcp.2024.116164_b0790","first-page":"58","article-title":"Activity of outpatient intravenous interleukin-2 and famotidine in metastatic clear cell kidney cancer","volume":"29","author":"Quan","year":"2014","journal-title":"Cancer Biother. Radiopharm."},{"issue":"8","key":"10.1016\/j.bcp.2024.116164_b0795","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00432-006-0095-7","article-title":"Immunotherapy Oncology Group for Renal Cell Carcinoma. Prospective randomized trial of natural interferon-alpha versus natural interferon-alpha plus cimetidine in advanced renal cell carcinoma with pulmonary metastasis","volume":"132","author":"Kinouchi","year":"2006","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bcp.2024.116164_b0800","doi-asserted-by":"crossref","unstructured":"H. Zhang, N.Wang, T. Yu, Q. Li, L. Yang, Y. Su, P. Wang, J. Liu, L. Yang, J. Zhang. Bioinformatic analysis on the prognostic value of neurotransmitter receptor-related genes in kidney renal clear cell carcinoma. Altern Ther Health Med. 2023 Aug 25:AT9022. Epub ahead of print. PMID: 37632962.","DOI":"10.21203\/rs.3.rs-2724393\/v1"},{"issue":"1","key":"10.1016\/j.bcp.2024.116164_b0805","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1046\/j.0022-202x.2001.01406.x","article-title":"Suppression of melanoma cell proliferation by histidine decarboxylase specific antisense oligonucleotides","volume":"117","author":"Hegyesi","year":"2001","journal-title":"J, Invest. Dermatol."},{"issue":"10","key":"10.1016\/j.bcp.2024.116164_b0810","doi-asserted-by":"crossref","first-page":"4458","DOI":"10.1158\/0008-5472.CAN-05-0011","article-title":"Phenotypic profiling of engineered mouse melanomas with manipulated histamine production identifies histamine H2 receptor and rho-C as histamine-regulated melanoma progression markers","volume":"65","author":"P\u00f3s","year":"2005","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.bcp.2024.116164_b0815","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1016\/j.febslet.2005.03.053","article-title":"Histamine elevates the expression of Ets-1, a protooncogen in human melanoma cell lines through H2 receptor","volume":"579","author":"Hegyesi","year":"2005","journal-title":"FEBS Lett."},{"issue":"7","key":"10.1016\/j.bcp.2024.116164_b0820","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1200\/JCO.1999.17.7.2105","article-title":"High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993","volume":"17","author":"Atkins","year":"1999","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116164_b0825","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3390\/jcm9010223","article-title":"Anti-PD-1 and novel combinations in the treatment of melanoma-an update","volume":"9","author":"Gellrich","year":"2020","journal-title":"J. Clin. Med."},{"issue":"6","key":"10.1016\/j.bcp.2024.116164_b0830","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/BF01534430","article-title":"Histamine in immunotherapy of advanced melanoma: a pilot study","volume":"39","author":"Hellstrand","year":"1994","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.bcp.2024.116164_b0835","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1158\/1078-0432.290.11.1","article-title":"Addition of histamine to interleukin 2 treatment augments type 1 T-cell responses in patients with melanoma in vivo: immunologic results from a randomized clinical trial of interleukin 2 with or without histamine (MP 104)","volume":"11","author":"Asemissen","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"7","key":"10.1016\/j.bcp.2024.116164_b0840","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1200\/JCO.1987.5.7.1078","article-title":"Phase II studies of single-agent cimetidine and the combination N-phosphonacetyl-L-aspartate (NSC-224131) plus L-alanosine (NSC-153353) in advanced malignant melanoma","volume":"5","author":"Morton","year":"1987","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.bcp.2024.116164_b0845","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/00000421-199110000-00007","article-title":"Phase II trial of cimetidine in metastatic melanoma. A hoosier oncology group trial","volume":"14","author":"Mandanas","year":"1991","journal-title":"Am. J. Clin. Oncol."},{"issue":"6 Suppl","key":"10.1016\/j.bcp.2024.116164_b0850","doi-asserted-by":"crossref","first-page":"188S","DOI":"10.1111\/1523-1747.ep12875512","article-title":"Disseminated malignant melanoma and recombinant interferon: analysis of seven consecutive phase II investigations","volume":"95","author":"Creagan","year":"1990","journal-title":"J, Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116164_b0855","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00008390-200010010-00009","article-title":"Subcutaneous interleukin-2 and interferon-alpha plus cisplatin with and without prophylactic cimetidine in patients with metastatic malignant melanoma: a phase II study","volume":"10","author":"Schmidt","year":"2000","journal-title":"Melanoma Res."},{"issue":"2","key":"10.1016\/j.bcp.2024.116164_b0860","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0936-6555(05)80858-1","article-title":"Sustained indomethacin and ranitidine with intermittent continuous infusion interleukin-2 in advanced malignant melanoma: a phase II study","volume":"5","author":"Mertens","year":"1993","journal-title":"Clin. Oncol. (R. Coll. Radiol.)"},{"issue":"6","key":"10.1016\/j.bcp.2024.116164_b0865","first-page":"607","article-title":"Continuous infusion interleukin-2 and intravenous famotidine in metastatic melanoma","volume":"21","author":"Quan","year":"2006","journal-title":"Cancer Biother. Radiopharm."},{"issue":"1","key":"10.1016\/j.bcp.2024.116164_b0870","first-page":"1","article-title":"Activity of continuous infusion + pulse interleukin-2 with famotidine in metastatic melanoma","volume":"24","author":"Quan","year":"2009","journal-title":"Cancer Biother. Radiopharm."},{"issue":"7","key":"10.1016\/j.bcp.2024.116164_b0875","first-page":"442","article-title":"Outpatient intravenous interleukin-2 with famotidine has activity in metastatic melanoma","volume":"27","author":"Quan","year":"2012","journal-title":"Cancer Biother. Radiopharm."},{"issue":"2","key":"10.1016\/j.bcp.2024.116164_b0880","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S0936-6555(96)80117-8","article-title":"Oral indomethacin and ranitidine in advanced melanoma: a phase II study","volume":"8","author":"Mertens","year":"1996","journal-title":"Clin. Oncol. (R. Coll. Radiol.)"},{"issue":"11","key":"10.1016\/j.bcp.2024.116164_b0885","first-page":"e48411","article-title":"Journey Through words: exploring esophageal cancer in literature","volume":"15","author":"Shahid","year":"2023","journal-title":"Cureus."},{"key":"10.1016\/j.bcp.2024.116164_b0890","unstructured":"H. Shiraishi-Yokoyama, H. Yokoyama, M. Matsumoto, H. Ishii. The existence of an NAD-dependent pathway for retinoic acid formation from vitamin A (retinol) in rat esophagus and its inhibition by ethanol and histamine 2 (H2) receptor antagonists. Med Sci Monit. 2003 Dec;9(12):BR403-6. PMID: 14646967."},{"issue":"285","key":"10.1016\/j.bcp.2024.116164_b0895","first-page":"13","article-title":"Post-cimetidine surveillance for up to ten years: incidence of carcinoma of the stomach and oesophagus","volume":"78","author":"Colin-Jones","year":"1991","journal-title":"Q. J. Med."},{"issue":"2","key":"10.1016\/j.bcp.2024.116164_b0900","first-page":"143","article-title":"Histamine-2-receptor antagonists and oesophageal cancer","volume":"6","author":"Fioretti","year":"1997","journal-title":"Eur. J. Cancer Prev."},{"issue":"5","key":"10.1016\/j.bcp.2024.116164_b0905","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0024-3205(83)90789-0","article-title":"Histamine and VIP interactions with receptor-cyclic AMP systems in the human gastric cancer cell line HGT-1","volume":"33","author":"Emami","year":"1983","journal-title":"Life Sci."},{"issue":"6\u20137","key":"10.1016\/j.bcp.2024.116164_b0910","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0192-0561(96)00044-6","article-title":"Comparison of antiproliferative effects of 1-histamine-2 receptor antagonists, cimetidine, ranitidine, and famotidine, in gastric cancer cells","volume":"18","author":"Hahm","year":"1996","journal-title":"Int. J. Immunopharmacol"},{"issue":"1","key":"10.1016\/j.bcp.2024.116164_b0915","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s40360-021-00533-7","article-title":"Famotidine promotes inflammation by triggering cell pyroptosis in gastric cancer cells","volume":"22","author":"Huang","year":"2021","journal-title":"BMC Pharmacol. Toxicol."},{"issue":"8618","key":"10.1016\/j.bcp.2024.116164_b0920","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/S0140-6736(88)90743-X","article-title":"Effect of cimetidine on survival after gastric cancer","volume":"2","author":"T\u00f8nnesen","year":"1988","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.bcp.2024.116164_b0925","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0277-5379(88)90247-7","article-title":"Clinical improvement in advanced cancer disease after treatment combining histamine and H2-antihistaminics (ranitidine or cimetidine)","volume":"24","author":"Burtin","year":"1988","journal-title":"Eur. J. Cancer Clin. Oncol."},{"key":"10.1016\/j.bcp.2024.116164_b0930","doi-asserted-by":"crossref","unstructured":"M.J. Langman, J.A. Dunn, J.L. Whiting, A. Burton, M.T. Hallissey, J.W. Fielding, D.J. Kerr, Prospective, double-blind, placebo-controlled randomized trial of cimetidine in gastric cancer. British Stomach Cancer Group, Br. J. Cancer 81 (8) (1999 Dec) 1356\u20131362, https:\/\/doi.org\/10.1038\/sj.bjc.6690457. PMID: 10604733; PMCID: PMC2362962.","DOI":"10.1038\/sj.bjc.6690457"},{"issue":"1","key":"10.1016\/j.bcp.2024.116164_b0935","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/s41572-021-00300-2","volume":"7","author":"Brindley","year":"2021","journal-title":"Cholangiocarcinoma. Nat Rev Dis Primers."},{"key":"10.1016\/j.bcp.2024.116164_b0940","doi-asserted-by":"crossref","unstructured":"H. Francis, S. DeMorrow, J. Venter, P. Onori, M. White, E. Gaudio, T. Francis. Inhibition of histidine decarboxylase ablates the autocrine tumorigenic effects of histamine in human cholangiocarcinoma. Gut. 2012 May;61(5):753-64. https:\/\/doi.org\/10.1136\/gutjnl-2011-300007. Epub 2011 Aug 26. PMID: 21873469; PMCID: PMC3244572.","DOI":"10.1136\/gutjnl-2011-300007"},{"issue":"5","key":"10.1016\/j.bcp.2024.116164_b0945","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1002\/hep.24573","article-title":"The H4 histamine receptor agonist, clobenpropit, suppresses human cholangiocarcinoma progression by disruption of epithelial mesenchymal transition and tumor metastasis","volume":"54","author":"Meng","year":"2011","journal-title":"Hepatology"},{"issue":"17","key":"10.1016\/j.bcp.2024.116164_b0950","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.3748\/wjg.v29.i17.2571","article-title":"Current and novel approaches in the pharmacological treatment of hepatocellular carcinoma","volume":"29","author":"Villarruel-Melquiades","year":"2023","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.bcp.2024.116164_b0955","first-page":"3347","article-title":"Upregulated histamine receptor H3 promotes tumor growth and metastasis in hepatocellular carcinoma","volume":"41","author":"Yu","year":"2019","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.bcp.2024.116164_b0960","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/emm.2007.32","article-title":"Histamine and spontaneously released mast cell granules affect the cell growth of human hepatocellular carcinoma cells","volume":"39","author":"Lampiasi","year":"2007","journal-title":"Exp. Mol. Med."},{"issue":"3","key":"10.1016\/j.bcp.2024.116164_b0965","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/j.1440-1746.2006.04541.x","article-title":"Cimetidine inhibits epidermal growth factor-induced cell signaling","volume":"22","author":"Fujikawa","year":"2007","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.bcp.2024.116164_b0970","unstructured":"S. Nishiguchi, A. Tamori, S. Shiomi, M. Enomoto, N. Tatsumi, N. Koh, D. Habu, H. Sakaguchi, T. Takeda, S. Seki, K. Nakamura, S. Kubo, H. Kinoshita. Cimetidine reduces impairment of cellular immunity after transcatheter arterial embolization in patients with hepatocellular carcinoma. Hepatogastroenterology. 2003 Mar-Apr;50(50):460-2. PMID: 12749247."},{"issue":"2","key":"10.1016\/j.bcp.2024.116164_b0975","first-page":"361","article-title":"Anti-tumor effects of cimetidine on hepatocellular carcinomas in diethylnitrosamine-treated rats","volume":"19","author":"Furuta","year":"2008","journal-title":"Oncol. Rep."},{"issue":"1","key":"10.1016\/j.bcp.2024.116164_b0980","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1038\/s41467-021-25468-9","article-title":"A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discovery","volume":"12","author":"Crouchet","year":"2021","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.bcp.2024.116164_b0985","doi-asserted-by":"crossref","first-page":"6644","DOI":"10.18632\/oncotarget.24019","article-title":"Pancreatic cancer: disease dynamics, tumor biology and the role of the microenvironment","volume":"9","author":"Ansari","year":"2018","journal-title":"Oncotarget"},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2024.116164_b0990","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1007\/PL00000188","article-title":"Human pancreatic carcinoma cell line Panc-I and the role of histamine in growth regulation","volume":"49","author":"Cricco","year":"2000","journal-title":"Inflamm. Res."},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2024.116164_b0995","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1007\/s00011-007-0611-5","article-title":"Histamine regulates pancreatic carcinoma cell growth through H3 and H4 receptors","volume":"57","author":"Cricco","year":"2008","journal-title":"Inflamm. Res."},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2024.116164_b1000","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.1007\/PL00022452","article-title":"Histamine inhibits proliferation of a pancreatic carcinoma cell line without inducing apoptosis significantly","volume":"51","author":"Martin","year":"2002","journal-title":"Inflamm. Res."},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2024.116164_b1005","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1007\/s00011-003-0331-4","article-title":"Histamine regulates the MAPK pathway via the H(2) receptor in PANC-1 human cells","volume":"53","author":"Cricco","year":"2004","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.bcp.2024.116164_b1010","unstructured":"G. Cricco, G. Mart\u00edn, V. Medina, M. N\u00fa\u00f1ez, N. Mohamad, M. Croci, E. Crescenti, R. Bergoc, E. Rivera. Histamine inhibits cell proliferation and modulates the expression of Bcl-2 family proteins via the H2 receptor in human pancreatic cancer cells. Anticancer Res. 2006 Nov-Dec;26(6B):4443-50. PMID: 17201167."},{"issue":"5","key":"10.1016\/j.bcp.2024.116164_b1015","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0061532","article-title":"Targeting mitochondrial STAT3 with the novel phospho-valproic acid (MDC-1112) inhibits pancreatic cancer growth in mice","volume":"8","author":"Mackenzie","year":"2013","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2024.116164_b1020","first-page":"S39","article-title":"Tumour growth inhibition of human pancreatic cancer xenografts in SCID mice by cimetidine","volume":"53","author":"S\u00fcr\u00fcc\u00fc","year":"2004","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.bcp.2024.116164_b1025","doi-asserted-by":"crossref","unstructured":"M.Housini, B. Dariya, N. Ahmed, A. Stevens, H. Fiadjoe, G.P. Nagaraju, R. Basha. Colorectal cancer: Genetic alterations, novel biomarkers, current therapeutic strategies and clinical trials. Gene. 2024 Jan 20;892:147857. https:\/\/doi.org\/10.1016\/j.gene.2023.147857. Epub 2023 Sep 30. PMID: 37783294.","DOI":"10.1016\/j.gene.2023.147857"},{"key":"10.1016\/j.bcp.2024.116164_b1030","doi-asserted-by":"crossref","unstructured":"L.E. Sander, A. Lorentz, G. Sellge, M. Co\u00ebffier, M. Neipp, T. Veres, T. Frieling, P.N. Meier, M.P. Manns, S.C. Bischoff. Selective expression of histamine receptors H1R, H2R, and H4R, but not H3R, in the human intestinal tract. Gut. 2006 Apr;55(4):498-504. https:\/\/doi.org\/10.1136\/gut.2004.061762. Epub 2005 Nov 18. PMID: 16299042; PMCID: PMC1856162.","DOI":"10.1136\/gut.2004.061762"},{"issue":"4","key":"10.1016\/j.bcp.2024.116164_b1035","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ejcb.2007.12.003","article-title":"Decreased expression of histamine H1 and H4 receptors suggests disturbance of local regulation in human colorectal tumours by histamine","volume":"87","author":"Boer","year":"2008","journal-title":"Eur. J. Cell Biol."},{"key":"10.1016\/j.bcp.2024.116164_b1040","doi-asserted-by":"crossref","unstructured":"T. Tanaka, T. Kochi, Y. Shirakami, T. Mori, A. Kurata, N. Watanabe, H. Moriwaki, M. Shimizu. Cimetidine and clobenpropit attenuate inflammation-associated colorectal carcinogenesis in male ICR mice. Cancers (Basel). 2016 Feb 20;8(2):25. doi: 10.3390\/cancers8020025. Erratum in: Cancers (Basel). 2017 Jul 05;9(7): PMID: 26907350; PMCID: PMC4773748.","DOI":"10.3390\/cancers9070080"},{"issue":"19 Pt 1","key":"10.1016\/j.bcp.2024.116164_b1045","doi-asserted-by":"crossref","first-page":"6807","DOI":"10.1158\/1078-0432.CCR-05-0675","article-title":"The role of cyclooxygenase-2 in mediating the effects of histamine on cell proliferation and vascular endothelial growth factor production in colorectal cancer","volume":"11","author":"Cianchi","year":"2005","journal-title":"Clin. Cancer Res."},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2024.116164_b1050","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1007\/s00011-004-0437-3","article-title":"Histamine and histidine decarboxylase up-regulation in colorectal cancer: correlation with tumor stage","volume":"54","author":"Masini","year":"2005","journal-title":"Inflamm. Res."},{"issue":"5","key":"10.1016\/j.bcp.2024.116164_b1055","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1006\/bbrc.2001.4487","article-title":"Effect of cimetidine on intratumoral cytokine expression in an experimental tumor","volume":"281","author":"Takahashi","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"5","key":"10.1016\/j.bcp.2024.116164_b1060","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.3390\/ijms24054913","article-title":"Histaminergic system and inflammation-related genes in normal large intestine and adenocarcinoma tissues: transcriptional profiles and relations","volume":"24","author":"Janikowska","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"12","key":"10.1016\/j.bcp.2024.116164_b1065","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1111\/j.1445-2197.1994.tb04562.x","article-title":"Cimetidine preserves non-specific immune function after colonic resection for cancer","volume":"64","author":"Adams","year":"1994","journal-title":"Aust. N. Z. J. Surg."},{"issue":"8","key":"10.1016\/j.bcp.2024.116164_b1070","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/(SICI)1097-0142(19990415)85:8<1658::AID-CNCR3>3.0.CO;2-Q","article-title":"Randomized trial of preoperative cimetidine in patients with colorectal carcinoma with quantitative assessment of tumor-associated lymphocytes","volume":"85","author":"Kelly","year":"1999","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.bcp.2024.116164_b1075","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3748\/wjg.v10.i1.136","article-title":"Perioperative cimetidine administration promotes peripheral blood lymphocytes and tumor infiltrating lymphocytes in patients with gastrointestinal cancer: Results of a randomized controlled clinical trial","volume":"10","author":"Lin","year":"2004","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.bcp.2024.116164_b1080","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jss.2005.02.030","article-title":"Effect of pre-operative short course famotidine on tumor infiltrating lymphocytes in colorectal cancer: a double blind, placebo controlled, prospective randomized study","volume":"129","author":"Kapoor","year":"2005","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.bcp.2024.116164_b1085","doi-asserted-by":"crossref","unstructured":"A.H. Ali, L. Hale, B. Yalamanchili, M. Ahmed, M. Ahmed, R. Zhou, S.E. Wright. The effect of perioperative cimetidine administration on time to colorectal cancer recurrence. Am J Ther. 2018 Jul\/Aug;25(4):e405-e411. https:\/\/doi.org\/10.1097\/MJT.0000000000000547. PMID: 29630589.","DOI":"10.1097\/MJT.0000000000000547"},{"key":"10.1016\/j.bcp.2024.116164_b1090","doi-asserted-by":"crossref","unstructured":"S. Deva, M. Jameson. Histamine type 2 receptor antagonists as adjuvant treatment for resected colorectal cancer. Cochrane Database Syst Rev. 2012 Aug 15;(8):CD007814. https:\/\/doi.org\/10.1002\/14651858.CD007814.pub2. PMID: 22895966.","DOI":"10.1002\/14651858.CD007814.pub2"},{"issue":"19","key":"10.1016\/j.bcp.2024.116164_b1095","doi-asserted-by":"crossref","first-page":"11046","DOI":"10.3390\/ijms231911046","article-title":"Current molecular combination therapies used for the treatment of breast cancer","volume":"23","author":"Wang","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2024.116164_b1100","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0006-2952(95)00108-C","article-title":"H1 and H2 histamine receptors in N-nitroso-N-methylurea (NMU)-induced carcinomas with atypical coupling to signal transducers","volume":"50","author":"Davio","year":"1995","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116164_b1105","doi-asserted-by":"crossref","DOI":"10.1007\/BF02007792","article-title":"Effect of histamine on growth and differentiation of the rat mammary gland","author":"Davio","year":"1994","journal-title":"Agents Actions"},{"key":"10.1016\/j.bcp.2024.116164_b1110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/BF01996451","article-title":"Inhibition of tumor growth induced by histamine: In vivo and in vitro studies","volume":"38","author":"Cricco","year":"1993","journal-title":"Agents Actions"},{"key":"10.1016\/j.bcp.2024.116164_b1115","series-title":"Histamine regulation of tumour growth. Role of H1 and H2 receptors, in Histamine in normal and cancer cell proliferation, Advances in the Bioscience","first-page":"299","author":"Rivera","year":"1993"},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2024.116164_b1120","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1007\/BF03354091","article-title":"Histamine regulates the expression of histidine decarboxylase in N-nitroso-N-methylurea (NMU)-induced mammary tumors in rats","volume":"45","author":"Engel","year":"1996","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.bcp.2024.116164_b1125","doi-asserted-by":"crossref","unstructured":"C.A. Davio, G.P. Cricco, N. Andrade, R.M. Bergoc, E.S. Rivera. H1 and H2 histamine receptors in human mammary carcinomas. Agents and Actions. 1993 Mar, 38(3-4) Special Conference Issue. C172-4. https:\/\/doi.org\/10.1007\/BF01996450.","DOI":"10.1007\/BF01996450"},{"issue":"Suppl 1","key":"10.1016\/j.bcp.2024.116164_b1130","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1007\/BF01674400","article-title":"Histamine receptors in human mammary gland, different benign lesions and mammary carcinomas","volume":"44","author":"Lemos","year":"1995","journal-title":"Inflamm. Res."},{"issue":"1","key":"10.1016\/j.bcp.2024.116164_b1135","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/PL00000276","article-title":"H1 and H2 histamine receptors mediate the production of inositol phosphates but not cAMP in human breast epithelial cells","volume":"51","author":"Davio","year":"2002","journal-title":"Inflamm. Res."},{"issue":"1","key":"10.1016\/j.bcp.2024.116164_b1140","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1254\/jphs.FP0070636","article-title":"Impact of systemic histamine deficiency on the crosstalk between mammary adenocarcinoma and T cells","volume":"105","author":"Hegyesi","year":"2007","journal-title":"J. Pharmacol. Sci."},{"issue":"6","key":"10.1016\/j.bcp.2024.116164_b1145","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.31557\/APJCP.2022.23.6.1847","article-title":"Cimetidine and Ibuprofen Modulate T Cell Responses in a Mouse Model of Breast Cancer","volume":"23","author":"Oladpour","year":"2022","journal-title":"Asian Pac. J. Cancer Prev."},{"issue":"4","key":"10.1016\/j.bcp.2024.116164_b1150","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1046\/j.1365-2168.1998.00625.x","article-title":"Histamine in human breast cancer","volume":"85","author":"Reynolds","year":"1998","journal-title":"Br. J. Surg."},{"issue":"1","key":"10.1016\/j.bcp.2024.116164_b1155","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1006\/scbi.2000.0301","article-title":"H2-antagonists in the treatment of colon and breast cancer","volume":"10","author":"Bolton","year":"2000","journal-title":"Semin. Cancer Biol."},{"issue":"9","key":"10.1016\/j.bcp.2024.116164_b1160","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.3389\/fimmu.2018.01894","article-title":"Ranitidine inhibition of breast tumor growth is B cell dependent and associated with an enhanced antitumor antibody response","volume":"15","author":"Rogers","year":"2018","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116164_b1165","doi-asserted-by":"crossref","first-page":"11514","DOI":"10.1038\/s41598-022-15551-6","article-title":"Anti-neoplastic action of Cimetidine\/Vitamin C on histamine and the PI3K\/AKT\/mTOR pathway in Ehrlich breast cancer","volume":"12","author":"Ibrahim","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2024.116164_b1170","doi-asserted-by":"crossref","unstructured":"B. Cao, Z. Zhang, C. Wang, X. Lv, Prognostic relevance of tumor-infiltrating lymphocytes in residual tumor tissue from patients with triple-negative breast cancer following neoadjuvant chemotherapy: A systematic review and meta-analysis, Oncol. Lett. 26 (4) (2023 Aug 24) 441, https:\/\/doi.org\/10.3892\/ol.2023.14028. PMID: 37664648; PMCID: PMC10472026.","DOI":"10.3892\/ol.2023.14028"},{"issue":"3","key":"10.1016\/j.bcp.2024.116164_b1175","first-page":"191","article-title":"Cimetidine does not influence TIL in breast cancer","volume":"1","author":"Dwerryhouse","year":"1999","journal-title":"Int. J. Surg. Investig."},{"issue":"6","key":"10.1016\/j.bcp.2024.116164_b1180","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1007\/s00432-022-04114-x","article-title":"Expression pattern and prognostic potential of histamine receptors in epithelial ovarian cancer","volume":"149","author":"Kraus","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.bcp.2024.116164_b1185","doi-asserted-by":"crossref","DOI":"10.3892\/mmr.1.1.119","article-title":"Prognostic implications of cimetidine on advanced serous ovarian carcinoma related to cyclooxygenase-2 expression","author":"Niwa","year":"2008","journal-title":"Mol. Med. Rep."},{"issue":"21","key":"10.1016\/j.bcp.2024.116164_b1190","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.3390\/jcm10214872","article-title":"Evaluation of the differences in the expression of biogenic amine-related mRNAs and proteins in endometrioid endometrial cancer","volume":"10","author":"Czerwi\u0144ski","year":"2021","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.bcp.2024.116164_b1195","doi-asserted-by":"crossref","unstructured":"Y. Wang, Y. Jiang, J. Ikeda, T. Tian, A. Sato, H. Ohtsu, E. Morii. Roles of histamine on the expression of aldehyde dehydrogenase 1 in endometrioid adenocarcinoma cell line. Cancer Med. 2014 Oct;3(5):1126-35. https:\/\/doi.org\/10.1002\/cam4.296. Epub 2014 Jul 10. PMID: 25045085; PMCID: PMC4302664.","DOI":"10.1002\/cam4.296"},{"issue":"2","key":"10.1016\/j.bcp.2024.116164_b1200","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0227552","article-title":"Overall survival and second primary malignancies in men with metastatic prostate cancer","volume":"15","author":"Meht\u00e4l\u00e4","year":"2020","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.bcp.2024.116164_b1205","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1002\/pros.1096","article-title":"Histamine H(1) receptor activation inhibits the proliferation of human prostatic adenocarcinoma DU-145 cells","volume":"48","author":"Valencia","year":"2001","journal-title":"Prostate"},{"key":"10.1016\/j.bcp.2024.116164_b1210","doi-asserted-by":"crossref","unstructured":"J. Chen, X.Y. Hu. Inhibition of histamine receptor H3R suppresses prostate cancer growth, invasion and increases apoptosis via the AR pathway. Oncol Lett. 2018 Oct;16(4):4921-4928. https:\/\/doi.org\/10.3892\/ol.2018.9310. Epub 2018 Aug 16. PMID: 30250558; PMCID: PMC6144779.","DOI":"10.3892\/ol.2018.9310"},{"issue":"2","key":"10.1016\/j.bcp.2024.116164_b1215","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/pros.2990170203","article-title":"Treatment of hormone-refractory stage D carcinoma of prostate with coumarin (1,2-benzopyrone) and cimetidine: a pilot study","volume":"17","author":"Marshall","year":"1990","journal-title":"Prostate"},{"issue":"3","key":"10.1016\/j.bcp.2024.116164_b1220","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/BF00204990","article-title":"The relationship between clinical stage, natural killer activity and related immunological parameters in adenocarcinoma of the prostate","volume":"28","author":"Lahat","year":"1989","journal-title":"Cancer Immunol. Immunother."},{"issue":"1","key":"10.1016\/j.bcp.2024.116164_b1225","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.lungcan.2011.05.029","article-title":"Mast cells and histamine enhance the proliferation of non-small cell lung cancer cells","volume":"75","author":"Stoyanov","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.bcp.2024.116164_b1230","doi-asserted-by":"crossref","unstructured":"V. Longo, A. Catino, M. Montrone, D. Galetta, D. Ribatti. Controversial role of mast cells in NSCLC tumor progression and angiogenesis. Thorac Cancer. 2022 Nov;13(21):2929-2934. https:\/\/doi.org\/10.1111\/1759-7714.14654. Epub 2022 Oct 4. PMID: 36196487; PMCID: PMC9626321.","DOI":"10.1111\/1759-7714.14654"},{"issue":"1","key":"10.1016\/j.bcp.2024.116164_b1235","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.molimm.2012.10.035","article-title":"Cimetidine suppresses lung tumor growth in mice through proapoptosis of myeloid-derived suppressor cells","volume":"54","author":"Zheng","year":"2013","journal-title":"Mol. Immunol."},{"issue":"13","key":"10.1016\/j.bcp.2024.116164_b1240","article-title":"Lung adenocarcinoma-related target gene prediction and drug repositioning","volume":"23","author":"Huang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2024.116164_b1245","unstructured":"J.J. Tsay, K.M. Tchou-Wong, A.K. Greenberg, H. Pass. Aryl hydrocarbon receptor and lung cancer. Anticancer Res. 2013 Apr;33(4):1247-56. PMID: 23564762; PMCID: PMC3771678."},{"issue":"11","key":"10.1016\/j.bcp.2024.116164_b1250","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/j.stem.2022.09.009","article-title":"Glioblastoma stem cell-specific histamine secretion drives pro-angiogenic tumor microenvironment remodeling","volume":"29","author":"Chen","year":"2022","journal-title":"Cell Stem Cell"},{"issue":"19","key":"10.1016\/j.bcp.2024.116164_b1255","doi-asserted-by":"crossref","first-page":"17107","DOI":"10.18632\/oncotarget.3672","article-title":"Inhibition of histamine receptor 3 suppresses glioblastoma tumor growth, invasion, and epithelial-to-mesenchymal transition","volume":"6","author":"Lin","year":"2015","journal-title":"Oncotarget"},{"issue":"14","key":"10.1016\/j.bcp.2024.116164_b1260","doi-asserted-by":"crossref","first-page":"22811","DOI":"10.18632\/oncotarget.15206","article-title":"Biological basis and clinical study of glycogen synthase kinase- 3\u03b2-targeted therapy by drug repositioning for glioblastoma","volume":"8","author":"Furuta","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.bcp.2024.116164_b1265","doi-asserted-by":"crossref","unstructured":"M.S. Nilsson, A. Hallner, M. Brune, S. Nilsson, F.B. Thor\u00e9n. Complete remission after the first cycle of induction chemotherapy determines the clinical efficacy of relapse-preventive immunotherapy in acute myeloid leukaemia. Br J Haematol. 2020 Feb;188(4):e49-e53. https:\/\/doi.org\/10.1111\/bjh.16320. Epub 2019 Dec 18. PMID: 31853942; PMCID: PMC7027927.","DOI":"10.1111\/bjh.16320"},{"key":"10.1016\/j.bcp.2024.116164_b1270","doi-asserted-by":"crossref","unstructured":"J. Aurelius, A. Martner, M. Brune, L. Palmqvist, M. Hansson, K. Hellstrand, F.B. Thoren. Remission maintenance in acute myeloid leukemia: impact of functional histamine H2 receptors expressed by leukemic cells. Haematologica. 2012 Dec;97(12):1904-8. https:\/\/doi.org\/10.3324\/haematol.2012.066399. Epub 2012 Jun 11. PMID: 22689678; PMCID: PMC3590096.","DOI":"10.3324\/haematol.2012.066399"},{"issue":"2","key":"10.1016\/j.bcp.2024.116164_b1275","doi-asserted-by":"crossref","first-page":"656","DOI":"10.4049\/jimmunol.137.2.656","article-title":"Histamine H2-receptor-mediated regulation of human natural killer cell activity","volume":"137","author":"Hellstrand","year":"1986","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.bcp.2024.116164_b1280","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/j.1600-0609.1996.tb01383.x","article-title":"NK cell-mediated killing of AML blasts: role of histamine, monocytes and reactive oxygen metabolites","volume":"57","author":"Brune","year":"1996","journal-title":"Eur. J. Haematol."},{"issue":"9","key":"10.1016\/j.bcp.2024.116164_b1285","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.bcp.2012.08.014","article-title":"Evidence for ligand-specific conformations of the histamine H(2)-receptor in human eosinophils and neutrophils","volume":"84","author":"Reher","year":"2012","journal-title":"Biochem. Pharmacol."},{"issue":"8","key":"10.1016\/j.bcp.2024.116164_b1290","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fonc.2018.00218","article-title":"Anti-Leukemic Properties of Histamine in Monocytic Leukemia: The Role of NOX2","volume":"18","author":"Kiffin","year":"2018","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bcp.2024.116164_b1295","doi-asserted-by":"crossref","unstructured":"D.R. Perez, L.A. Sklar, A. Chigaev, K. Matlawska-Wasowska. Drug repurposing for targeting cyclic nucleotide transporters in acute leukemias - A missed opportunity. Semin Cancer Biol. 2021 Jan;68:199-208. https:\/\/doi.org\/10.1016\/j.semcancer.2020.02.004. Epub 2020 Feb 7. PMID: 32044470; PMCID: PMC7415530.","DOI":"10.1016\/j.semcancer.2020.02.004"},{"key":"10.1016\/j.bcp.2024.116164_b1300","doi-asserted-by":"crossref","unstructured":"S. Copsel, C. Garcia, F. Diez, M. Vermeulem, A. Baldi, L.G. Bianciotti. Multidrug resistance protein 4 (MRP4\/ABCC4) regulates cAMP cellular levels and controls human leukemia cell proliferation and differentiation. J Biol Chem. 2011 Mar 4;286(9):6979-88. https:\/\/doi.org\/10.1074\/jbc.M110.166868. Epub 2011 Jan 4. PMID: 21205825; PMCID: PMC3044954.","DOI":"10.1074\/jbc.M110.166868"},{"issue":"1","key":"10.1016\/j.bcp.2024.116164_b1305","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1007\/s12032-020-01452-z","article-title":"Comparative randomized trial evaluating the effect of proton pump inhibitor versus histamine 2 receptor antagonist as an adjuvant therapy in diffuse large B-cell lymphoma","volume":"38","author":"Hegazy","year":"2021","journal-title":"Med. Oncol."},{"issue":"5","key":"10.1016\/j.bcp.2024.116164_b1310","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1002\/phar.1739","article-title":"Adjunct histamine blockers as premedications to prevent carboplatin hypersensitivity reactions","volume":"36","author":"Mach","year":"2016","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.bcp.2024.116164_b1315","doi-asserted-by":"crossref","unstructured":"J.M. Cox, L. van Doorn, R. Malmberg, E. Oomen-de. The added value of H2 antagonists in premedication regimens during paclitaxel treatment. Br J Cancer. 2021 May;124(10):1647-1652. https:\/\/doi.org\/10.1038\/s41416-021-01313-0. Epub 2021 Mar 24. PMID: 33762718; PMCID: PMC8110571.","DOI":"10.1038\/s41416-021-01313-0"},{"issue":"4","key":"10.1016\/j.bcp.2024.116164_b1320","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.985","article-title":"Ranitidine and the incidence of hypersensitivity reactions to paclitaxel: A retrospective cohort study","volume":"10","author":"Haine","year":"2022","journal-title":"Pharmacol. Res. Perspect."},{"issue":"23","key":"10.1016\/j.bcp.2024.116164_b1325","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1002\/cncr.35006","article-title":"The utility of H2 receptor antagonists in preventing infusion-related reactions to paclitaxel chemotherapy","volume":"129","author":"Tsang","year":"2023","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.bcp.2024.116164_b1330","first-page":"133","article-title":"Protective effect of time-modulated cimetidine on methotrexate-induced liver toxicity","volume":"6","author":"Adikwu","year":"2020","journal-title":"Pharm. Biomed. Res."},{"issue":"12","key":"10.1016\/j.bcp.2024.116164_b1335","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1158\/1940-6207.CAPR-14-0002","article-title":"Proton pump inhibitors and histamine 2 blockers are associated with improved overall survival in patients with head and neck squamous carcinoma","volume":"7","author":"Papagerakis","year":"2014","journal-title":"Cancer Prev. Res. (Phila.)"},{"issue":"1","key":"10.1016\/j.bcp.2024.116164_b1340","first-page":"79","article-title":"Lafutidine, a histamine H2 receptor antagonist with mucosal protective properties, attenuates 5-fluorouracil-induced intestinal mucositis in mice through activation of extrinsic primary afferent neurons","volume":"68","author":"Sano","year":"2017","journal-title":"J. Physiol. Pharmacol."},{"issue":"12","key":"10.1016\/j.bcp.2024.116164_b1345","first-page":"7297","article-title":"Feasibility study of supportive care using lafutidine, a histamine H2 receptor antagonist, to prevent gastrointestinal toxicity during chemotherapy for gastric cancer","volume":"34","author":"Namikawa","year":"2014","journal-title":"Anticancer Res"},{"issue":"11","key":"10.1016\/j.bcp.2024.116164_b1350","doi-asserted-by":"crossref","first-page":"8495","DOI":"10.1002\/jcp.29692","article-title":"Cimetidine a promising radio-protective agent through modulating Bax\/Bcl2 ratio: An in vivo study in male rats","volume":"235","author":"Estaphan","year":"2020","journal-title":"J. Cell. Physiol."},{"issue":"3","key":"10.1016\/j.bcp.2024.116164_b1355","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1080\/10715760290019264","article-title":"Protective effects of cimetidine on radiation-induced micronuclei and apoptosis in human peripheral blood lymphocytes","volume":"36","author":"Kojima","year":"2002","journal-title":"Free Radic. Res."},{"key":"10.1016\/j.bcp.2024.116164_b1360","unstructured":"E. Samei, H. Mozdarani, F. Samiei, G.H. Javadi. Radioprotective effects of combined melatonin and famotidine treatment on radiation induced apoptosis in peripheral blood leukocytes of breast cancer patients and normal individuals. Cell J. 2021 Oct;23(5):562-567. https:\/\/doi.org\/10.22074\/cellj.2021.7378. Epub 2021 Oct 30. PMID: 34837684; PMCID: PMC8588819."},{"issue":"8","key":"10.1016\/j.bcp.2024.116164_b1365","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00066-014-0602-8","article-title":"Famotidine as a radioprotector for rectal mucosa in prostate cancer patients treated with radiotherapy: phase I\/II randomized placebo-controlled trial","volume":"190","author":"Razzaghdoust","year":"2014","journal-title":"Strahlenther. Onkol."},{"issue":"1","key":"10.1016\/j.bcp.2024.116164_b1370","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s13014-023-02281-w","article-title":"Effectiveness of oral famotidine in reducing the hematologic complications of radiotherapy in patients with esophageal and cardia cancers: a randomized controlled trial","volume":"18","author":"Rostami","year":"2023","journal-title":"Radiat. Oncol."},{"issue":"2","key":"10.1016\/j.bcp.2024.116164_b1375","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00411-015-0586-5","article-title":"Potent radioprotective effects of combined regimens of famotidine and vitamin C against radiation-induced micronuclei in mouse bone marrow erythrocytes","volume":"54","author":"Zangeneh","year":"2015","journal-title":"Radiat. Environ. Biophys."},{"issue":"8","key":"10.1016\/j.bcp.2024.116164_b1380","doi-asserted-by":"crossref","first-page":"808","DOI":"10.2174\/1389200216666150223152627","article-title":"CYP3A4-mediated pharmacokinetic interactions in cancer therapy","volume":"15","author":"Tian","year":"2014","journal-title":"Curr. Drug Metab."},{"issue":"2020","key":"10.1016\/j.bcp.2024.116164_b1385","first-page":"3028387","article-title":"The multifarious link between cytochrome P450s and cancer","volume":"3","author":"Alzahrani","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"5","key":"10.1016\/j.bcp.2024.116164_b1390","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1124\/dmd.122.001131","article-title":"Activation\/inactivation of anticancer drugs by CYP3A4: influencing factors for personalized cancer therapy","volume":"51","author":"Wang","year":"2023","journal-title":"Drug Metab. Dispos."},{"issue":"4","key":"10.1016\/j.bcp.2024.116164_b1395","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0009-9236(99)70129-3","article-title":"Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H2-receptor antagonists","volume":"65","author":"Mart\u00ednez","year":"1999","journal-title":"Clin. Pharmacol. Ther."},{"issue":"2","key":"10.1016\/j.bcp.2024.116164_b1400","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1007\/s10549-011-1641-9","article-title":"Japan breast cancer research group (JBCRG). Correlation between docetaxel-induced skin toxicity and the use of steroids and H\u2082 blockers: a multi-institution survey","volume":"130","author":"Kawaguchi","year":"2011","journal-title":"Breast Cancer Res. Treat."},{"issue":"1","key":"10.1016\/j.bcp.2024.116164_b1405","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0936-6555(98)80109-X","article-title":"The effect of cimetidine on the pharmacokinetics of epirubicin in patients with advanced breast cancer: preliminary evidence of a potentially common drug interaction","volume":"10","author":"Murray","year":"1998","journal-title":"Clin. Oncol. (R. Coll. Radiol.)"},{"issue":"8","key":"10.1016\/j.bcp.2024.116164_b1410","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1182\/blood-2010-07-294330","article-title":"Drug interactions with the tyrosine kinase inhibitors imatinib, dasatinib, and nilotinib","volume":"117","author":"Haouala","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2024.116164_b1415","doi-asserted-by":"crossref","unstructured":"O.Q. Yin, F.J. Giles, M. Baccarani, P. le Coutre, O. Chiparus, N. Gallagher, G. Saglio, T.P. Hughes. Concurrent use of proton pump inhibitors or H2 blockers did not adversely affect nilotinib efficacy in patients with chronic myeloid leukemia. Cancer Chemother Pharmacol. 2012 Aug;70(2):345-50. https:\/\/doi.org\/10.1007\/s00280-012-1881-3. Epub 2012 May 24. PMID: 22623211; PMCID: PMC5557057.","DOI":"10.1007\/s00280-012-1881-3"},{"issue":"6","key":"10.1016\/j.bcp.2024.116164_b1420","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1007\/s12185-020-02845-6","article-title":"Influence of proton pump inhibitors and H2-receptor antagonists on the efficacy and safety of dasatinib in chronic myeloid leukemia patients","volume":"111","author":"Koutake","year":"2020","journal-title":"Int. J. Hematol."},{"issue":"6","key":"10.1016\/j.bcp.2024.116164_b1425","doi-asserted-by":"crossref","first-page":"e433","DOI":"10.1016\/j.cllc.2017.05.010","article-title":"Effects of histamine 2-receptor antagonists and proton pump inhibitors on the pharmacokinetics of gefitinib in patients with non-small-cell lung cancer","volume":"18","author":"Yokota","year":"2017","journal-title":"Clin. Lung Cancer"},{"issue":"8711","key":"10.1016\/j.bcp.2024.116164_b1430","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0140-6736(90)91888-H","article-title":"Histamine-2-receptor antagonists and gastric cancer risk","volume":"336","author":"La Vecchia","year":"1990","journal-title":"Lancet"},{"issue":"2 Suppl","key":"10.1016\/j.bcp.2024.116164_b1435","doi-asserted-by":"crossref","first-page":"81S","DOI":"10.1007\/BF02214873","article-title":"Effects of acid suppression on microbial flora of upper gut","volume":"40","author":"Yeomans","year":"1995","journal-title":"Dig. Dis. Sci."},{"issue":"2","key":"10.1016\/j.bcp.2024.116164_b1440","first-page":"100","article-title":"Proton pump inhibitors and histamine-2 receptor antagonists on the risk of pancreatic cancer: a systematic review and meta-analysis","volume":"113","author":"Laoveeravat","year":"2020","journal-title":"QJM"},{"key":"10.1016\/j.bcp.2024.116164_b1445","doi-asserted-by":"crossref","unstructured":"N. Brusselaers, O. Sadr-Azodi, L. Engstrand. Long-term proton pump inhibitor usage and the association with pancreatic cancer in Sweden. J Gastroenterol. 2020 Apr;55(4):453-461. https:\/\/doi.org\/10.1007\/s00535-019-01652-z. Epub 2019 Dec 6. PMID: 31811561; PMCID: PMC7080689.","DOI":"10.1007\/s00535-019-01652-z"},{"issue":"49","key":"10.1016\/j.bcp.2024.116164_b1450","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000032228","article-title":"Use of proton pump inhibitors for the risk of gastric cancer","volume":"101","author":"Gao","year":"2022","journal-title":"Medicine (Baltimore)"},{"issue":"20","key":"10.1016\/j.bcp.2024.116164_b1455","doi-asserted-by":"crossref","first-page":"5172","DOI":"10.3390\/cancers14205172","article-title":"Use of proton pump inhibitors and the risk for the development of gastric cancers: a nationwide population-based cohort study using balanced operational definitions","volume":"14","author":"Gong","year":"2022","journal-title":"Cancers (Basel)."},{"issue":"6","key":"10.1016\/j.bcp.2024.116164_b1460","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.14309\/ajg.0000000000001167","article-title":"Use of proton pump inhibitors vs histamine 2 receptor antagonists for the risk of gastric cancer: population-based cohort study","volume":"116","author":"Shin","year":"2021","journal-title":"Am. J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.bcp.2024.116164_b1465","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s00228-020-02927-8","article-title":"The association between acid-suppressive agent use and the risk of cancer: a systematic review and meta-analysis","volume":"76","author":"Song","year":"2020","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"5","key":"10.1016\/j.bcp.2024.116164_b1470","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/apt.16464","article-title":"No association between chronic use of ranitidine, compared with omeprazole or famotidine, and gastrointestinal malignancies","volume":"54","author":"Kim","year":"2021","journal-title":"Aliment. Pharmacol. Ther."},{"issue":"5","key":"10.1016\/j.bcp.2024.116164_b1475","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1007\/s10620-021-06972-w","article-title":"Ranitidine use and gastric cancer among persons with helicobacter pylori","volume":"67","author":"Kumar","year":"2022","journal-title":"Dig. Dis. Sci."},{"issue":"9","key":"10.1016\/j.bcp.2024.116164_b1480","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.33495","article-title":"Ranitidine Use and Incident Cancer in a Multinational Cohort","volume":"6","author":"You","year":"2023","journal-title":"JAMA Netw. Open"},{"issue":"8","key":"10.1016\/j.bcp.2024.116164_b1485","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.14309\/ajg.0000000000001310","article-title":"Exposure to ranitidine and risk of bladder cancer: a nested case-control study","volume":"116","author":"Cardwell","year":"2021","journal-title":"Am. J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.bcp.2024.116164_b1490","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s40264-020-01024-0","article-title":"Risk of cancer in association with ranitidine and nizatidine vs other H2 blockers: analysis of the japan medical data center claims database 2005\u20132018","volume":"44","author":"Iwagami","year":"2021","journal-title":"Drug Saf."},{"issue":"2","key":"10.1016\/j.bcp.2024.116164_b1495","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/(SICI)1099-1557(200003\/04)9:2<149::AID-PDS481>3.0.CO;2-1","article-title":"Cimetidine use and risk of breast, prostate, and other cancers","volume":"9","author":"Habel","year":"2000","journal-title":"Pharmacoepidemiol. Drug Saf."},{"issue":"4","key":"10.1016\/j.bcp.2024.116164_b1500","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1158\/1055-9965.EPI-04-0547","article-title":"Cimetidine and other histamine2-receptor antagonist use in relation to risk of breast cancer","volume":"14","author":"Coogan","year":"2005","journal-title":"Cancer Epidemiol. Biomarkers Prev."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224001473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295224001473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,15]],"date-time":"2024-10-15T00:24:46Z","timestamp":1728951886000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295224001473"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":300,"alternative-id":["S0006295224001473"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116164","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"H2 antihistamines: May be useful for combination therapies in cancer?","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2024.116164","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"116164"}}